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Older adults experience diverse patterns of cognitive state changes, including progression to 
dementia, that depend on genetic and non-genetic factors. With population aging, the global 
prevalence of dementia is rising. Given limited treatment success, research focusing on patterns of 
cognitive state changes and their predictors provides information for older adults and opens windows 
to develop interventions for preventing or delaying the onset of dementia.  
This dissertation is based on analyzing secondary data from the Nun Study, a longitudinal study of 
aging and cognition. The first aim of this dissertation was to identify patterns of changes over time in 
cognitive states among older adults using a clinically-driven approach and a statistical modeling 
method, and to compare the patterns identified using these two methods. The second aim was to test 
and quantify how academic achievement—educational attainment and academic performance in high 
school—is associated with cognitive state changes and contributes to cognitive reserve. The third aim 
was to test the potential antagonistic pleiotropy effect of the gene apolipoprotein E (APOE) on 
cognition. 
To identify the patterns of cognitive state changes (Aim 1), homogeneous trajectories were grouped 
together using two different approaches: 1) a clinically-driven approach, and 2) a statistical modeling 
approach, latent class mixed-effects modeling (lcmm). Using the clinically-driven approach, seven 
patterns were identified based on whether individuals experienced stable or non-stable trajectories 
and among non-stable trajectories, whether they experienced a reverse transition to an improved 
cognitive state, whether they developed dementia or both. These seven trajectories ranged from stable 
normal cognition to stable dementia. These patterns were preferred to the four classes identified using 
latent class mixed-effects modeling. This preference was based on the higher level of detail in 
trajectories captured by the clinically-driven approach compared to the latent classes identified using 
the lcmm approach. These details include distinguishing between trajectories with and without 
cognitive improvement, and with and without progression to dementia. The patterns of cognitive state 
changes based on the clinically-driven approach were then used as the cognitive outcomes to address 





Using multinomial logistic bias reduction regression, the potential presence of cognitive reserve 
among individuals with higher academic achievement was tested (Aim 2). Adjusting for age and 
APOE, higher educational attainment (i.e., a graduate degree) was associated with higher odds of 
experiencing three healthier patterns of cognitive state changes. Higher overall academic performance 
was significantly associated with experiencing stable cognitive impairment or cognitive impairment 
without dementia; this effect was mostly due to higher performance in algebra rather than 
performance in English, Latin, or geometry courses. Higher academic achievement, as evidenced by 
educational attainment or performance in high school courses, was thus associated with cognitive 
reserve through experiencing healthier patterns of cognitive trajectories versus experiencing stable 
dementia. 
To test the potential antagonistic pleiotropy effect of APOE on cognition, the effect of APOE-ε4 on 
both early- and late-life cognition was investigated (Aim 3). In addition, the potential modifying 
effect of higher education among APOE-ε4 carriers was tested. APOE-ε4 was not significantly 
associated with an early-life measure of cognition (educational attainment); however, among 
individuals with lower education, APOE-ε4 was associated with experiencing the most impaired 
cognitive pattern (stable dementia) in late life. This research did not support the antagonistic 
pleiotropy hypothesis for APOE; however, it did support the scaffolding theory of aging and 
cognition. Higher educational attainment among APOE-ε4 carriers compensated for the detrimental 
effects of APOE-ε4 on late-life cognition to the extent that APOE-ε4 carriers with high educational 
attainment (a graduate degree) showed cognitive aging patterns similar to APOE-ε4 non-carriers. This 
modifying effect of higher education on the association between APOE-ε4 and late-life cognition 
suggests that higher education is associated with cognitive reserve even among APOE-ε4 carriers. 
This dissertation provides information on patterns of cognitive state changes and their predictors in 
older adults that will benefit older adults, their families, and the healthcare system. Patterns of 
cognitive trajectories among older adults are diverse, complex, and difficult to identify. Advanced 
statistical approaches and their software applications are developed for modeling complex 
longitudinal cognitive trajectories; however, integrating clinically-driven approaches in identifying 
distinct patterns of cognitive state changes is beneficial. The results of this dissertation show that 





cognitive trajectories. While APOE-ε4 and older age are non-modifiable risk factors for dementia, it 
may be possible to compensate for their detrimental effects through a modifiable factor, such as 
graduate-level education. Therefore, investing in higher education is an important potential 
intervention that may prevent or delay dementia even among individuals carrying a genetic risk 
factor. Furthermore, it may be worthwhile for researchers targeting APOE to develop interventions 
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1.1 Cognitive aging 
Cognitive aging refers to changes in cognitive abilities over time. Similar to cognitive aging 
earlier in life, cognitive aging later in life (typically defined as age 65 years and older) is a 
continuum (Petersen, 1995; Petersen et al., 1997). Among older adults, normal cognitive aging is 
maintaining a level of cognitive ability that is typical for older adults who, with aging, might 
experience some levels of cognitive decline but have reasonably normal cognitive function 
(Petersen et al., 1997; Schaie, 1994). However, cognitive decline in older adults might exceed 
that typical age-related level of impairment and decline further to mild cognitive impairment 
(MCI) and dementia (Petersen et al., 1997). While standardized diagnostic criteria for MCI and 
dementia do not exist yet (Christa Maree Stephan et al., 2013), the clinical relevance of these 
states is recognized, as is the importance of studying the range of cognitive states from normal 
cognition to dementia to understand cognitive aging in older adults. In this thesis, the whole 
spectrum of cognitive aging is studied and referred to as changes in cognitive abilities over time 
among older adults. 
1.1.1 Normal cognitive aging, cognitive decline, and dementia 
Dementia is an umbrella term to describe a collection of clinical symptoms of cognitive 
impairment in multiple domains that interfere with activities of daily living (Tyas & Gutmanis, 
2015; Voelker, 2008). Dementia has several causes with Alzheimer’s disease being the most 
common, accounting for approximately two-thirds of cases (American Psychiatric Association, 
1994; Chouliaras, Topiwala, Cristescu, & Ebmeier, 2015; Prince et al., 2013), and vascular 
dementia being the second most common, accounting for approximately 5 to 10% of cases 
(Alzheimer's Association, 2019). It has been increasingly recognized that Alzheimer and 





initially thought, particularly in the oldest age groups (Rahimi & Kovacs, 2014; Schneider, 
Arvanitakis, Bang, & Bennett, 2007). 
Clinically, individuals who develop dementia start with normal cognitive aging and usually go 
through an MCI phase before developing dementia. This process is described by the cognitive 
continuum model (Petersen, 1995; Petersen et al., 1997). Types of dementia have diverse timings 
and etiology, with typical pathological changes underlying the most common subtypes. For 
example, Alzheimer pathology—amyloid plaques and neurofibrillary tangles—is thought to 
begin 20 to 30 years before deterioration reaches a level that leads to clinical symptoms of 
cognitive impairment or dementia (Fisher, Plassman, Heeringa, & Langa, 2008; Howieson et al., 
2003; Jack et al., 2013; Nilsson et al., 2010; Perneczky et al., 2006; Rijal Upadhaya et al., 2014; 
Sperling et al., 2011). Similarly, the pathology associated with vascular dementia—
cerebrovascular disease due to arteriosclerotic changes in the cerebral vasculature—begins a 
long time prior to reaching a level to cause clinical cognitive impairment or dementia, or causing 
the stroke which in turn may lead to post-stroke dementia (Kalaria, 2018). 
1.1.2 Impact of dementia 
Normal cognitive aging is associated with well-being and health-related quality of life (Davis et 
al., 2015). However, the majority of older adults experience some level of cognitive impairment 
(Petersen, 2011). Prevalence and level of cognitive impairment increase with aging. For 
example, dementia affects about 5% of older adults 65 years and older, and 30% of those 80 and 
over (Jorm, Korten, & Henderson, 1987; Ritchie & Lovestone, 2002). Therefore, older age is a 
major risk factor for cognitive decline and dementia (Jagger & Lindesay, 1993; Tyas & 
Gutmanis, 2015; World Health Organization, 2012). Worldwide, the population of older adults is 
increasing. The global population of older adults was 654 million (8.7% of the world’s 
population) in 2017 (World Bank, 2017) and it is anticipated to increase to 1.6 billion by 2050 





increases in the number of older adults, the global prevalence of dementia is also expected to 
increase. 
Dementia is the most feared aspect of the aging experience (Bazalgette et al., 2011). It is one 
of the most disabling health conditions and is a major public health problem (Ferri et al., 2005; 
Tyas & Gutmanis, 2015). With limited treatment success, research focusing on patterns of 
cognitive state changes and their predictors provides information for older adults and opens 
windows for preventing or delaying the onset of dementia (Singh-Manoux & Kivimäki, 2010; 
Voelker, 2008).  
1.1.3 Assessment of cognition 
Cognition can be assessed as an overall ability (e.g., based on performance on a global cognitive 
test, such as the Mini-Mental State Examination (MMSE)) or in relation to various domains—
such as attention, executive function, learning and memory, language, motor function, and social 
cognition—using neuropsychological tests (American Psychiatric Association, 2013). To 
diagnose the cognitive state of an older adult, overall cognitive ability, performance in specific 
cognitive domains, and activities of daily living (ADL) are assessed and compared over time (M. 
S. Albert et al., 2011; McKhann, Drachman, & Folstein, 1984; McKhann et al., 2011; Riley, 
Snowdon, & Markesbery, 2002). The cognitive continuum is usually categorized into three 
cognitive states: intact cognition, a cognitive impairment state less severe than dementia (e.g., 
MCI), and dementia (Kryscio, Schmitt, Salazar, Mendiondo, & Markesbery, 2006; Petersen, 
1995). 
Results of cognitive assessments are most useful when compared longitudinally. For example, 
on tests such as the MMSE, older adults with cognitive impairment and high levels of 
educational attainment may earn scores typically associated with normal cognition. Conversely, 
among older adults with low levels of educational attainment, those with normal cognition may 





cognitive trajectories over time (Small et al., 1997)—i.e., examining cognitive change over time 
in the same individual. 
1.2 Longitudinal trajectories of cognitive aging 
Studying longitudinal trajectories of cognitive aging is superior to investigating cognitive aging 
in cross-sectional studies because the latter provides a snapshot of just one point in the cognitive 
trajectory and cannot identify the cognitive state changes over time. Given that cognitive 
deterioration may start 20 years before the onset of dementia (Sperling et al., 2011), and that risk 
factors can influence cognitive trajectories during these decades before dementia (Tyas et al., 
2007), understanding trajectories early in the process of cognitive decline as well as the 
predictors of healthier cognitive trajectories will support initiatives to build cognitive reserve and 
prevent or delay cognitive impairment or dementia. 
Currently, cognitive trajectories have been studied with three perspectives: 1) transition 
between cognitive states; 2) trajectories of specific domains; and 3) trajectories of overall 
cognition, based on overall cognition tests (e.g., MMSE) or on a combined score calculated from 
tests on specific domains. Literature on longitudinal trajectories of cognitive aging is presented 
in Chapters 2 and 4. The overall patterns of cognitive trajectories based on cognitive states are 
not well characterized, even though cognitive states (e.g., normal cognition, MCI, and dementia) 
are the primary ways cognition is described in clinical practice.  
1.3 Factors associated with longitudinal trajectories of cognitive aging 
To increase the chance of healthy cognitive aging, it is important to identify its predictors. Other 
than aging, genetic and non-genetic factors may interact to increase the risk of cognitive 
impairment or its progression to dementia (Bagyinszky, Youn, An, & Kim, 2014). In this thesis, 
the effect of sociodemographic factors, intellectual factors, and apolipoprotein E (APOE), the 
most important genetic risk factor for dementia and more specifically for Alzheimer’s disease 
(Bagyinszky et al., 2014), will be studied. In addition, two theories of aging will be tested: the 





  The antagonistic pleiotropy theory for an allele is a concept in evolutionary biology that 
refers to beneficial effects of an allele earlier in life and its adverse effects later in life (Medawar, 
1952; Williams, 1957). The scaffolding theory of aging and cognition may clarify how a 
combination of adverse and compensatory neural processes may influence cognition later in life 
(Park & Reuter-Lorenz, 2009; Reuter-Lorenz & Park, 2014). In this thesis, the antagonistic 
pleiotropy hypothesis will be tested by studying the effect of APOE on cognition earlier and later 
in life—through the association of APOE with educational attainment earlier in life and with 
patterns of cognitive state changes later in life. The scaffolding theory of aging and cognition 
will be tested by studying whether higher educational attainment may compensate for the 
detrimental effects of the ԑ4 allele of APOE gene on cognition. Literature on the effect of 
sociodemographic factors and intellectual factors on cognitive aging is presented in Chapters 3 
and 5. Literature on the effect of APOE on cognition earlier and later in life is presented in 
Chapters 3 and 6.  
1.4 Goals and implications 
Learning about cognitive decline prior to dementia and prevention of dementia is a public health 
priority. This dissertation identified patterns of cognitive state changes and factors associated 
with experiencing these different patterns. Using clinically-driven and statistical modeling 
approaches, this research identified patterns of cognitive state changes through four cognitive 
states ranging from normal cognition to dementia, with two intermediary cognitive impairment 
states in between. Then, the association between academic achievement—educational attainment 
and academic performance—and experiencing different patterns of cognitive state changes was 
investigated. Finally, a life-span effect of a genetic factor on cognition was tested. This 
longitudinal analysis of patterns of cognitive state changes and their predictors is among the first 






The results of this dissertation will contribute to the knowledge of expected patterns of age-
related cognitive state changes and their predictors, providing valuable information for older 
adults, their families, care partners, and healthcare systems in planning for care, treatment, and 
support. Furthermore, researchers designing clinical trials for intervention will benefit from this 
knowledge for planning those trials, including the recruitment of participants. In addition, 
knowledge of patterns of cognitive state changes will provide an opportunity to investigate the 







This chapter presents an overview of the literature on cognitive aging in older adults and the 
effect of academic achievement and apolipoprotein E (APOE) on cognitive aging. One of the 
most frequently asked questions regarding cognition later in life is about the potential patterns of 
cognitive state changes and their predictors. The temporal changes in cognitive states are not 
well characterized, even though cognitive states (e.g., normal cognition, mild cognitive 
impairment [MCI], and dementia) are the primary ways cognition is described in clinical 
practice. Preliminary research has attempted to identify the potential patterns of cognitive state 
changes among older adults. However, due to the limited availability and the complexity of the 
analytical approaches to analyze longitudinal ordinal cognitive states, in contrast to continuous 
cognitive outcomes, researchers have not examined the trajectories of cognitive state changes in 
much detail. However, research on other aspects of cognitive aging in older adults has identified 
heterogeneity in cognitive function upon reaching older age, in rates of cognitive decline, and in 
potential improvements to a higher cognitive level that suggest the importance of attention to 
such details when modeling trajectories of cognitive state changes. 
2.1 Cognitive aging  
Cognitive aging among older adults is usually assumed to follow a decline trajectory. However, 
both earlier (Brayne, Huppert, Paykel, & Gill, 1992; Lyketsos, Chen, & Anthony, 1999) and 
more recent studies (Malek-Ahmadi, 2016; Xue et al., 2019) provide growing evidence that 
cognitive aging is heterogeneous among older adults and includes stable MCI and improvement 
from MCI to normal cognition.  
The foundation for research on trajectories of cognitive state changes in older adults has been 
established based on studying cognitive aging: 1) within specific domains such as learning or 
memory; 2) through tests that measure overall cognition using a single test such as the Mini-





3) using a more comprehensive measure of cognition based on composite scores across multiple 
cognitive tests and domains. Some studies have considered more than one of these measures to 
model trajectories of cognitive aging (Bretsky et al., 2003; McCarrey, An, Kitner-Triolo, 
Ferrucci, & Resnick, 2016; D. Mungas et al., 2010). For example, Zaninotto et al. (2018) studied 
three cognitive domains (memory, executive function, and processing speed) and a global 
cognitive function based on these three domains to study cognitive aging. They showed that 
postsecondary education was associated with higher levels of memory, executive function, 
processing speed, and global cognitive score, and with a faster decline in global cognitive 
function. A limitation of the study by Zaninotto et al. (2018), however, is that in their analytic 
sample of 10,626 individuals, the heterogeneity of cognitive decline was not fully considered 
because only one overall cognitive aging trajectory was modelled, and individual variability may 
be more than the differences between individuals reflected in an overall baseline score or rate of 
decline.  
Other studies have chosen to capture the heterogeneity of cognitive decline with several 
patterns (Baker et al., 2017; Hofer et al., 2002; McCarrey et al., 2016; D. Mungas, Early, 
Glymour, Zeki Al Hazzouri, & Haan, 2018; Thibeau, McFall, Camicioli, & Dixon, 2017; Yaffe 
et al., 2009). For example, Barker et al. (2017) identified six distinct patterns in MMSE scores to 
describe cognitive aging in their analytic sample of 3441 individuals. Individuals in these six 
patterns had five different levels of MMSE at baseline, and two patterns with similar cognitive 
levels at baseline had different rates of decline. A limitation of this study is in their measure of 
cognition, which was based on only one type of test, and in not capturing any potential stable 
cognition or reversion to a higher MMSE score for some individuals.      
 Fewer studies have examined composite scores across multiple cognitive tests or domains to 
identify points of change in rate of cognitive decline (Wilson et al., 2012). Wilson et al. (2012) 
showed an association between more years of education and a delay in increased accelerated 
decline (when clinical diagnosis of dementia occurs at an older age for individuals with higher 





decline is faster in those with higher educational attainment). One aspect of cognitive aging that 
was missed in this study was consideration of trajectories with cognitive improvement versus 
cognitive decline. The authors presented a figure for individual cognitive trajectories, which 
displayed patterns of both improvement and decline among participants (Wilson et al., 2012). 
This aspect of cognitive trajectories most often has been studied in modeling transitions between 
cognitive states as ordinal cognitive outcomes based on combining scores across multiple 
cognitive tests (Abner et al., 2012; Wei & Kryscio, 2016). For example, Wei et al. (2016) found 
that carrying a genetic risk factor for dementia (apolipoprotein E-ԑ4 (APOE-ԑ4)) and low levels 
of education (high school or less) was associated with lower odds of reversion from MCI to 
normal cognition. A limitation of such studies that model both reverse transitions from MCI to 
normal cognition and progression to MCI and dementia, however, is that they miss modelling the 
temporal changes in cognitive states. 
A study by Aiken-Morgan et al. (2017) found four distinct patterns of cognitive state changes 
with temporal changes in cognitive states that included both reversion from MCI to normal 
cognition and progression from MCI to dementia. However, they did not provide information on 
the analytic method used to identify the patterns of cognitive state changes. Description of the 
methods used to identify distinct patterns of cognitive state changes is important because 
analyzing longitudinal data on aging and cognition is complex; to contribute to progress in 
research on modeling patterns of cognitive state changes, clear analytical methodology is 
required that can be replicated and improved. 
Studies of aging in cognitive domains provide useful information on cognitive aging within 
domains and also model trajectories with improvement to better cognitive function. However, 
these studies do not provide a global perspective that identifies whether individuals who 
experienced improvement within one domain also experienced improvement within other 
domains, or whether their overall cognitive state declined or improved when experiencing 
trajectories of decline and improvement within domains. Also, studies of transitions between 





2.2 Education and cognitive reserve  
Lower education is associated with higher prevalence of dementia (Zhang et al., 1990), and 
higher education is considered to contribute to cognitive reserve (Y. Stern, Albert, Tang, & Tsai, 
1999). It is suggested that cognitive reserve is the ability of a brain with damage to function at a 
normal level or at least a higher level than would be expected with that level of brain damage (Y. 
Stern, 2002; Y. Stern, 2009; Y. Stern et al., 1999). In addition, lifetime cognitive stimulation is 
suggested to delay or even prevent brain damage through delaying hippocampal atrophy 
(Valenzuela, Sachdev, Wen, Chen, & Brodaty, 2008) or preventing accumulation of amyloid 
plaques (Landau et al., 2012). 
Longitudinal studies of aging and cognition have observed that educational attainment is 
associated with potential cognitive reserve as shown through four categories of evidence on the 
effects of higher educational attainment: 1) higher cognitive performance upon reaching older 
adulthood (Alley, Suthers, & Crimmins, 2007; McDermott, McFall, Andrews, Anstey, & Dixon, 
2016; D. Mungas et al., 2018; Muniz-Terrera et al., 2009; Tucker-Drob, Johnson, & Jones, 2009; 
Wilson et al., 2019; Zahodne et al., 2011; Zahodne, Stern, & Manly, 2015); 2) slower cognitive 
decline compared to older adults with lower educational attainment (Alley et al., 2007; 
McDermott et al., 2016; Reas et al., 2017; Zahodne et al., 2015); 3) delayed accelerated decline 
(when clinical diagnosis of dementia occurs at an older age for individuals with higher than with 
lower educational attainment, but once reserve is exhausted and decline begins, this decline is 
faster in those with higher educational attainment (Castro-Costa et al., 2011; Clouston et al., 
2019; Hall et al., 2007; Wattmo, Londos, & Minthon, 2014); and 4) greater probability of 
reversion from MCI to normal cognition (Canevelli et al., 2016; Iraniparast et al., 2016).  
The first two of these four categories on how higher educational attainment increases the 
chance of cognitive reserve are usually studied together. For example, Alley et al. (2007), 
McDermott et al. 2016, and Zahodne et al. (2015) have found an association between higher 
education and higher cognitive performance upon reaching older adulthood and also slower 





some studies examining these two categories have only found a significant association between 
higher education and higher cognitive performance upon reaching older adulthood, and not 
slower cognitive decline compared to older adults with lower educational attainment (D. Mungas 
et al., 2018; Tucker-Drob et al., 2009; Wilson et al., 2019; Zahodne et al., 2011). Several 
methodological aspects of these studies could have led to such a discrepancy in the results (e.g., 
differences in age of the analytic sample at baseline, length of follow-up in the longitudinal 
study, measures of cognition, levels of education and other characteristics of the sample, sample 
size, and analytical approach). For example, in the study by Zahodne et al. (2011), using linear 
growth modeling, higher education was only associated with cognition at baseline and not with 
rate of cognitive decline. However, in another study by Zahodne et al. (2015), using second-
order latent growth curve modeling, higher education was associated with both cognition at 
baseline and slower cognitive decline. While these two studies had many other different 
characteristics, the differences in analytic approach could explain the variation in results since in 
another study by McDermott et al. (2016) using latent growth mixture modeling, higher 
education was again associated with higher cognitive level at baseline and slower rate of decline. 
Using nonlinear latent growth curve modeling, McArdle (2011) showed that individuals with 
higher education had higher cognitive scores at all ages.  
An example of a study that investigated cognitive reserve through the association between 
education and cognitive decline is by Hall et al. (2007). In a sample of incident cases of 
dementia, they found that more years of education were associated with a delay in the rate of 
accelerated cognitive decline, with increasing years of education associated with more delay and 
faster decline. Finally, studies on the association between education and transitions between 
cognitive states found that higher education was associated with an increased odds of reversion 
from MCI to normal cognition (Canevelli et al., 2016; Sachdev et al., 2013; Xue et al., 2019). 
The first three categories of evidence on how educational attainment is associated with 
cognitive reserve among older adults modeled cognition through temporal cognitive trajectories. 





trajectories of change in memory scores (Hall et al., 2007), these studies did not identify whether 
individuals with higher education experienced cognitive improvement (i.e., reversion to a less 
impaired state). Therefore, individual cognitive trajectories with improvements were combined 
with individual trajectories of cognitive impairment contributing to an average cognitive decline. 
On the other hand, although reversion is investigated in the fourth category of evidence, these 
studies did not model temporal cognitive trajectories for individuals who experience reverse 
transitions, such as whether those who experience reverse transitions eventually developed 
dementia.  
2.3 Apolipoprotein E and cognition  
2.3.1 Apolipoprotein E and cognition earlier in life 
The association between APOE and cognition has been studied in children and younger adults. 
Previous research on the effect of APOE on cognition has shown that the APOE-ε4 allele may be 
associated with higher cognitive abilities earlier in life. In children and young adults, APOE-ε4 
was associated with better cognitive performance as reflected in infant development (Wright et 
al., 2003), visuospatial processing (Bloss, Delis, Salmon, & Bondi, 2010), verbal fluency 
(Marchant, King, Tabet, & Rusted, 2010), decision making (Marchant et al., 2010), 
neuropsychological tests (Han & Bondi, 2008), IQ scores (Yu, Lin, Chen, Hong, & Tsai, 2000), 
and educational attainment (Hubacek et al., 2001). However, other studies have not found this 
beneficial effect of APOE-ε4 on cognition earlier in life (Bretsky et al., 2003; O'Donoghue, 
Murphy, Zamboni, Nobre, & Mackay, 2018). 
2.3.2 Apolipoprotein E and cognition later in life 
For the first time in 1993, the ε4 allele of the APOE gene was observed to be associated with 
Alzheimer’s disease, the most common type of dementia (Corder et al., 1993; Strittmatter et al., 
1993). Since then, the effect of APOE-ԑ4 on Alzheimer’s disease has been replicated in hundreds 





factor for Alzheimer’s disease (Ali, Smart, & Gawryluk, 2018; Y. Liu et al., 2015; Ward et al., 
2012). Other than the effect of APOE-ԑ4 on Alzheimer’s disease, APOE-ԑ4 increases the risk of 
all-cause dementia (Llewellyn et al., 2010) and cognitive impairment less severe than dementia 
(Oveisgharan et al., 2018; Sun et al., 2018; Tyas et al., 2007). 
2.3.2.1 The biological effect of apolipoprotein E-ԑ4 on increasing the risk of dementia 
The APOE gene exerts its effect in the body through the apoE protein (Roses, 1996). ApoE is the 
most prevalent brain lipoprotein, is the main carrier of cholesterol in the brain, and is involved in 
neuronal maintenance and repair (Bagyinszky et al., 2014; Michaelson, 2014). Among human 
organs, the brain has the highest level of cholesterol (Shobab, Hsiung, & Feldman, 2005). An 
important role of apoE is to clear cholesterol from the brain extracellular matrix (Heverin et al., 
2004). Individuals coding the ԑ4 type of the apoE protein cannot properly transport cholesterol 
from the brain to the bloodstream (Shobab et al., 2005). This impairment in clearing cholesterol 
from the brain is associated with the formation of extracellular amyloid plaques (Shobab et al., 
2005).  
In general, apoE is observed in both amyloid plaques and neurofibrillary tangles, 
neuropathological brain damage associated with Alzheimer’s disease (Namba, Tomonaga, 
Kawasaki, Otomo, & Ikeda, 1991). However, based on autopsy assessment of those with 
Alzheimer’s disease, being APOE-ԑ4-positive was related to more frequent plaques and tangles 
than being APOE-ԑ4-negative (Hansen et al., 1994; Nagy et al., 1995; Schmechel et al., 1993). In 
addition, those with Alzheimer’s disease who were APOE-ԑ4-positive showed more severe brain 
degeneration than those who were APOE-ԑ4-negative and also showed significantly more 
impaired synaptic plasticity (Arendt et al., 1997), hippocampal atrophy (Poirier et al., 1995), and 
brain inflammation (Egensperger, Kosel, von Eitzen, & Graeber, 1998). Therefore, a wide range 
of evidence shows that APOE-ԑ4 is related to the main pathological hallmarks of Alzheimer’s 





2.3.2.2 Therapeutic approaches based on apolipoprotein E-ԑ4  
Despite numerous research efforts, a cure for dementia has yet to be discovered and no 
treatments affect the course of the disease (Fereshtehnejad, Johnell, & Eriksdotter, 2014; 
Gauthier et al., 2012; Kryscio et al., 2013; Mangialasche, Kivipelto, Solomon, & Fratiglioni, 
2012; Richens et al., 2013; Ungar, Altmann, & Greicius, 2014). Current strategies for controlling 
dementia are based on treatments that help to manage the symptoms for mild to moderate 
dementia (Ho et al., 2019; Iqbal, Gong, & Liu, 2014; Richens et al., 2013; Trivedi et al., 2019). 
After a number of phase III clinical trials that targeted amyloid plaques for developing a cure for 
Alzheimer’s disease failed, APOE-ԑ4 is being considered as a new therapeutic target (Bales & 
Paul, 2019; Safieh, Korczyn, & Michaelson, 2019; Uddin et al., 2019). To develop a therapeutic 
strategy for prevention, researchers need to know how APOE-ԑ4 is associated with the trajectory 
of cognitive decline. 
2.3.3 Apolipoprotein E and cognition earlier and later in life (antagonistic pleiotropy) 
Combining the studies of the association between APOE and cognition both earlier and later in 
life shows that while APOE-ε4 is a risk factor for dementia, APOE-ε4 carriers may benefit from 
carrying this allele earlier in life. The APOE gene has thus been suggested to have an 
antagonistic pleiotropy effect on cognition (Alexander et al., 2007; Tuminello & Han, 2011; 
Wright et al., 2003). The theory of antagonistic pleiotropy was first introduced in the field of 
evolutionary biology by Medawar (1952) and Williams (1957). A potential antagonistic 
pleiotropy effect for a gene refers to a potential beneficial effect of a genetic allele earlier in life 
contrasted with its adverse effects later in life.  
Tuminello & Han (2011) suggested that because the effect of APOE-ε4 on cognition differs 
among younger and older individuals, assessing the interaction between age and APOE-ε4 when 
studying the effect of APOE-ε4 on cognition may be a valuable addition to investigations of the 
antagonistic pleiotropy hypothesis. However, previous research on APOE-ε4 and cognition 





2014; Wright et al., 2003); therefore, this interaction cannot be tested in these studies. One study 
by Luciano et al. (2009) that investigated the effect of APOE-ε4 on cognition was a stratified 
analysis for the effect of APOE on cognition both earlier and later in life within the same cohort 
of individuals. This research did not show a significant association between APOE-ε4 and IQ in 
early life; however, it did show a significant association between APOE-ε4 and lower nonverbal 
cognition in old age.  
2.3.4 The scaffolding theory of aging and cognition as a complementary theory to the 
antagonistic pleiotropy hypothesis 
The scaffolding theory of aging and cognition (Park & Reuter-Lorenz, 2009; Reuter-Lorenz & 
Park, 2014) is a theoretical model more recent than, and complementary to, the antagonistic 
pleiotropy hypothesis. This scaffolding theory aims to clarify how a combination of adverse and 
compensatory neural processes may influence cognitive aging. A compensatory neural process 
suggests recruitment of additional neuronal paths in the brain avoids the detrimental effects of 
adverse factors on cognitive aging. This is complementary to the antagonistic pleiotropy effect of 
APOE-ε4 on cognition, suggesting that APOE-ε4 carriers with higher educational attainment 
(even if their higher educational attainment is not due to an earlier beneficial effect of the APOE-
ε4 allele) may have a combination of at least two factors: one that has an adverse effect on 
cognition (carrying an APOE-ε4 allele) and one that has a compensatory effect on cognition 
(higher educational attainment). These factors may interact to influence cognitive aging. 
Therefore, according to the scaffolding theory of aging and cognition it may be assumed that 
APOE-ε4 carriers with high educational attainment, which might be due to the beneficial effects 
of APOE on early-life cognition, may develop a reserve that will compensate for the detrimental 
effects of APOE-ε4 on late-life cognition, such that their risk of dementia would be similar to 
APOE-ε4 non-carriers. Thus far, several studies have found that higher educational attainment 
earlier in life could modify the detrimental effect of APOE-ε4 on cognition later in life (Arenaza-
Urquijo et al., 2015; Reas et al., 2019; Tyas et al., 2007) although other studies have not found 





(Ngandu et al., 2007). It has also been suggested that such an interaction may only be present 
among men (Hasselgren et al., 2019).  
Overall, while some evidence indicates that higher education may modify the effect of APOE-
ε4 on cognition among older adults, these studies have not determined whether APOE-ε4 is also 
associated with higher educational attainment earlier in life. Therefore, evidence is lacking on 



















Study Rationale and Research Questions 
3.1 Study rationale 
Cognitive transitions that lead to developing MCI and dementia follow unique linear and 
nonlinear patterns in cognitive domains over years (Howieson et al., 2008; Sperling et al., 2011). 
This long period is associated with complex cognitive trajectories, such as remaining in the 
normal cognitive state, reversion from MCI to normal cognition, or gradually declining towards 
dementia. Identifying the patterns of cognitive trajectories with aging and their predictors will 
provide crucial information for older adults, their families, and the healthcare system in planning 
for care, treatment, and support.  
Few studies have investigated the full spectrum of trajectories of overall cognition and their 
predictors (Aiken-Morgan, Gamaldo, Wright, Allaire, & Whitfield, 2017; M. Albert, Blacker, 
Moss, Tanzi, & McArdle, 2007; Karlamangla et al., 2009; Wilson et al., 2012). In addition to 
studies of the transitions between cognitive states, cognitive trajectories have been studied 
focusing on three types of cognitive measures: 1) specific cognitive domains; 2) specific 
cognitive tests (e.g., MMSE); and 3) composite scores across multiple cognitive tests and 
domains. However, the overall patterns of cognitive trajectories based on cognitive states are not 
well characterized, even though cognitive states (e.g., normal cognition, MCI, and dementia) are 
the primary ways cognition is described.  
While the adverse effect of APOE-ε4 on late-life cognitive trajectories has been investigated 
using longitudinal studies (Albrecht et al., 2015; Hofer et al., 2002; Iraniparast et al., 2016; Tyas 
et al., 2007), its effect on the trajectories of overall cognitive state changes is not established. In 
addition, the potential beneficial effect of APOE-ε4 on educational attainment in the same 
population who will be studied for their later-life cognitive trajectories has not been studied 
before, and how educational attainment might modify the effect of APOE-ε4 on those trajectories 





identified and the association between specific risk factors and these cognitive trajectories were 
examined.   
For the first question of this dissertation, patterns of cognitive trajectories were identified using 
two distinct approaches: 1) a clinically-driven method and 2) a statistical modeling approach, 
latent class mixed-effects modeling (lcmm). This statistical method for analyzing longitudinal 
data considers both the mixed modeling theory that accounts for correlation between repeated 
longitudinal measurements for individuals, and the latent class modeling theory that 
discriminates homogeneous latent classes (Proust-Lima, Philipps, & Liquet, 2017) (see Section 
4.2.3.2). Then, the latent classes identified using the statistical modeling approach were 
compared with classes identified using the clinically-driven approach.  
The potential predictors of these patterns of cognitive trajectories were identified in Research 
Questions 2 and 3. For the second research question, the association between academic 
achievement (educational attainment and academic performance in high school) and patterns of 
cognitive trajectories were investigated. The effect of higher educational attainment on reduced 
risk of dementia is well established. In this dissertation, the effect on membership in patterns of 
cognitive trajectories of higher academic achievement that includes both educational attainment 
and better performance in high school courses was examined.  
For the third research question, the effect of APOE on later-life patterns of cognitive 
trajectories was studied. APOE-ε4 is a risk factor for Alzheimer’s disease, the most common 
cause of dementia. However, the effect of APOE on cognitive trajectories is not clear and may be 
modified by the level of education attained earlier in life (Shadlen et al., 2005). Based on the 
antagonistic pleiotropy hypothesis (Williams, 1957), although carrying an APOE-ε4 allele is a 
risk factor for cognitive decline later in life, it may have beneficial effects in early life, increasing 
the probability of attaining a higher level of education, which is a protective factor for dementia 





3.2 Research questions and hypotheses  
The overall objective of this research is to identify the heterogeneous patterns of cognitive state 
changes, and to identify the factors associated with membership in these distinct patterns of 
cognitive trajectories. 
Research Question 1: What are the patterns of cognitive state changes among older adults 
identified using a clinically-driven approach and a statistical modeling method, and how do the 
patterns of cognitive state changes identified using these two methods compare? (Chapter 4) 
Hypothesis 1: Three categories of cognitive trajectories are expected to be observed: 1) fixed-
state trajectories of cognitive impairment: individuals who remain in the same state of cognitive 
impairment (i.e., MCI, global impairment (GI), or dementia) over the study period; 2) trajectories 
that represent cognitive reserve (e.g., reflecting stable normal cognition or cognitive 
improvement): for example, individuals who show some level of cognitive impairment (MCI or 
GI) and then revert back to normal cognition; and 3) trajectories that represent gradual cognitive 
decline: for example, individuals who start with normal cognition, and then decline to MCI, GI, 
and possibly dementia. 
Research Question 2: Is academic achievement—educational attainment and academic 
performance in high school—associated with cognitive reserve through membership in healthier 
patterns of cognitive state changes later in life? (Chapter 5) 
Hypothesis 2: Higher levels of academic achievement are expected to be associated with 
cognitive reserve, reflected in a greater chance of experiencing healthier patterns of cognitive 
state changes, such as patterns with constant normal cognition, patterns with reverse transition 
from cognitive impairment to normal cognition, or patterns with cognitive decline without 
dementia.  
Research Question 3: Is APOE associated with higher educational attainment earlier in life and 





antagonistic pleiotropy effect on cognition)? Does higher education among APOE-ε4 carriers 
compensate for the detrimental effects of APOE-ε4 on cognition later in life? (Chapter 6) 
Hypothesis 3: APOE has an antagonistic pleiotropy effect on cognition: carrying an APOE-ε4 
allele is associated with higher educational attainment earlier in life, and higher risk of 
membership in the least healthy pattern of cognition later in life. APOE-ε4 carriers with higher 
educational attainment experience patterns of cognitive trajectories that are similar to non-






Longitudinal Patterns of Cognitive State Changes among Older Adults: 
Comparing Results from Clinically-Driven and Statistical Modeling Methods  
4.1 Introduction  
One of the most frequently asked questions regarding cognition later in life is about the potential 
patterns of cognitive state changes, with particular concerns about the trajectory of cognitive 
decline to dementia. However, due to the limited availability and considerable complexity of the 
analytical approaches needed to analyze longitudinal ordinal cognitive states, researchers have 
not yet investigated the trajectories of cognitive state changes in much detail.  
Cognition in late life is usually assumed to show a downward trajectory. However, 
longitudinal studies of aging and overall cognition show that, with aging, older adults experience 
improvement as well as decline in their cognitive performance. Research shows evidence of 
healthy cognitive aging (Brayne et al., 1992; Lyketsos et al., 1999) and improvement from mild 
impairment to normal cognition without eventual progression to dementia (Abner et al., 2012; 
Iraniparast et al., 2016; Koepsell & Monsell, 2012; Sachdev et al., 2013). Reports of these 
healthier patterns of cognitive aging are encouraging for older adults and their families, and are 
important for life and care planning for these individuals as well as the healthcare system. 
The foundation for research on trajectories of cognitive state changes in older adults has been 
established based on studying cognitive performance as a continuous measure rather than as 
cognitive states. These foundational studies have assessed: 1) specific cognitive domains 
(Bretsky et al., 2003; Hall, Lipton, Sliwinski, & Stewart, 2000; Hofer et al., 2002; McCarrey et 
al., 2016; McDermott et al., 2016; D. Mungas et al., 2010; Singer, Verhaeghen, Ghisletta, 
Lindenberger, & Baltes, 2003; Thibeau et al., 2017; Zaninotto, Batty, Allerhand, & Deary, 
2018); 2) specific cognitive tests (e.g., Mini-Mental State Examination (MMSE) or Clinical 
Dementia Rating—Sum of Boxes (CDR–SB)) (M. Albert et al., 2007; Baker et al., 2017; Brayne 





scores across multiple cognitive tests (Karlamangla et al., 2009; Wilson et al., 2012). These 
longitudinal studies of aging and cognition show that older adults start their journey of cognitive 
aging at different levels and experience decline at diverse rates. These studies provide good 
information on cognitive aging within domains and individual and combined cognitive test 
scores, and also model trajectories with improvement. However, these studies do not provide 
information on the clinically important measure of overall cognitive function, and thus cannot 
identify whether individuals who experienced improvement within one domain (or individual or 
composite test score) also experienced improvement within other domains or tests, or whether 
their overall cognitive state declined or improved when experiencing trajectories of decline and 
improvement within domains.   
To address this limitation, researchers have also focused on modeling overall cognitive states. 
Using neuropsychological tests of cognitive domains, tests of overall cognition, and abilities in 
activities of daily living (ADL), individuals are diagnosed with distinct cognitive states. Then, 
these cognitive states are modeled through transitions between cognitive states or through 
patterns of change.  
Examples of studies that modeled transitions between cognitive states include modeling 
transitions from normal cognition to mild cognitive impairment (MCI) and from MCI to 
dementia (Kryscio, Yu, Snowdon, & Tyas, 2008; Riley et al., 2000; Tyas et al., 2007), or from 
MCI back to normal cognition (Abner et al., 2012; Iraniparast et al., 2016). Modeling transitions 
between cognitive states provides information on separate transitions between states; however, it 
does not provide information on temporal changes in cognitive states. Modeling patterns of 
cognitive state changes is an approach to address this limitation of modeling transitions between 
cognitive states. Studying patterns of cognitive state changes distinguishes temporal changes in 
cognitive state changes and can also identify distinct patterns. This perspective of studying 
patterns of cognitive state changes is similar to studies of specific cognitive domains when they 





The only study of patterns of cognitive state changes published to date is limited by its focus 
on sociodemographic characteristics of participants rather than on describing the methods used to 
identify the clusters of cognitive trajectories (Aiken-Morgan et al., 2017). Description of the 
methods used to identify distinct patterns of cognitive state changes is important because 
analyzing longitudinal data on aging and cognition is complex; to contribute to progress in 
research on modeling patterns of cognitive state changes, clear analytical methodology is 
required that can be replicated and improved.  
Applying a clinically-driven approach allows allocation of individuals into different patterns of 
cognitive state changes that are clinically valid; however, it is a manual, time-consuming process 
and only a limited number of characteristics can be considered when assigning individuals into 
patterns. Automated analytic methods hold promise to address these limitations, but such 
methods have not yet been fully investigated. Previous research has applied latent class mixed-
effects modeling (lcmm) (Proust-Lima et al., 2017) approaches to studies of preclinical dementia 
to identify temporal changes in cognition and daily functioning (Rajan et al., 2019; Verlinden et 
al., 2016) and to studies of Alzheimer’s disease to identify distinct patterns of change in severity 
of clinical symptoms (Geifman, Kennedy, Schneider, Buchan, & Brinton, 2018). However, the 
validity of applying lcmm to identify latent classes of cognitive state changes in older adults in 
comparison to clinically-driven patterns of cognitive state changes has not been examined. The 
aims of this study were to identify and compare patterns of cognitive state changes among older 
adults using: 1) a clinically-driven approach, and 2) a statistical modeling method, lcmm.  
4.2 Methods 
4.2.1 Sample 
This research is based on secondary data from the Nun Study, a longitudinal cohort study of 
aging and cognition. The participants are American members of a religious congregation, the 
School Sisters of Notre Dame. Between 1991 and 1993, all members who were 75 years or older 





invited to join the Nun Study (N=1,031), and 678 (66%) volunteered to participate (Butler, 
Wesson, & Snowdon, 1996). These volunteers did not differ significantly from nonparticipants 
in their average age at baseline, mortality rate, race, and country of birth (Snowdon et al., 1996). 
The timeline of data collection for the Nun Study is presented in Figure 4-1. The analytic sample 
for this study is the 574 participants who had at least one follow-up cognitive assessment and 







The Nun Study participants 
were born before 1917. 
 
Recruitment of religious sisters 75+ years 
began in 1991 and continued until 1993. 
Collection of data until death or 
12th round of assessment in 2007 
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The longitudinal data on cognitive states for each participant were used to identify the 
patterns of cognitive state changes. These longitudinal data were based on approximately 
annual cognitive assessments from 1991 until death or the end of the 12th round of 
assessments. Individuals needed to have at least one follow-up cognitive assessment after 
their baseline assessment to be included in the longitudinal data analysis. In the Nun Study, 
104 individuals had only one cognitive assessment (92 of these 104 died within two years of 
their initial assessment, reflecting the relatively low loss to follow-up in this sample other 
than through attrition by death). Therefore, for this study, the analytic sample is 678 – 104 = 
574. More than 87% (504 out of 574) of the participants were followed until death. The 
remaining 70 individuals were alive at the end of the assessment period and thus their 
remaining cognitive trajectories until death were not observed.  
4.2.2 Measures 
Age at each cognitive assessment was calculated based on date of birth (from convent 
archives) and date of assessment. Cognitive state at each assessment was categorized as one 
of four mutually exclusive states: normal cognition, MCI, global impairment (GI), or 
dementia. The criteria for assigning individuals to these cognitive states have been described 
previously (Riley et al., 2002; Snowdon et al., 1996; Tyas et al., 2007) and are summarized 
briefly below and also in Appendix A, Table A-1. 
Normal cognition. Participants with normal cognition had intact cognition in four cognitive 
tests (Riley et al., 2002) in the neuropsychological battery of the Consortium to Establish a 
Registry for Alzheimer's Disease (CERAD) (≥14 for Boston Naming, ≥12 for Verbal 
Fluency, ≥5 for Delayed Word Recall, and ≥9 for Constructional Praxis) (Morris et al., 1989; 
Welsh et al., 1994), intact global cognition based on the MMSE (≥24) (Folstein, Folstein, & 






feeding, dressing, walking, standing [transferring], and toileting) (Kuriansky & Gurland, 
1976; Potvin et al., 1972). 
Mild cognitive impairment. Participants with MCI were diagnosed based on having at least 
one specific area of impaired cognition (e.g., memory or naming) based on four cognitive 
tests from the CERAD neuropsychological battery, but with intact global cognition based on 
the MMSE (≥24), intact function in at least four out of five performance-based ADL, and not 
meeting criteria for dementia (Kuriansky & Gurland, 1976; Potvin et al., 1972). The cut-off 
point used for impairment in each test was 1.5 standard deviations below age-appropriate 
means, consistent with established definitions (Petersen et al., 1997; Petersen et al., 1999; 
Petersen, 2011; Smith, Petersen, Parisi, & Ivnik, 1996). 
Global impairment. Participants with GI had impairment in global cognitive function 
(MMSE < 24), in performance-based ADL, or both. They were also impaired in at least one 
out of four tests from the CERAD neuropsychological battery. However, participants with GI 
did not meet criteria for dementia because if they had impairment in two areas of cognition, 
they were intact for performance-based ADL (≥4) (Riley et al., 2002; Riley, Snowdon, 
Desrosiers, & Markesbery, 2005). 
Dementia. For a diagnosis of dementia, a participant had to have an impairment in memory 
and in at least one other cognitive domain based on the CERAD neuropsychological battery, 
impairment in performance-based ADL, and a decline from previous cognitive level 






using scores below the 5th percentile of age norms in the CERAD battery (Morris et al., 1989; 
Welsh et al., 1994). 
4.2.3 Analysis 
The characteristics of the sample were described using standard univariate analyses. Then the 
patterns of cognitive state changes were identified based on two approaches: 1) a clinically-
driven approach and 2) a statistical modeling method. 
A participant’s cognitive status at each assessment was recorded as an ordinal value with 
normal cognition representing the highest level of cognition followed by MCI and then GI; 
dementia represented the lowest level of cognition. The cognitive status assessments over 
time produce a sequence of longitudinal ordinal outcomes for each participant that we call a 
single trajectory of cognitive state changes. To identify the overall patterns of cognitive state 
changes for all participants, homogeneous trajectories were grouped together. Then, groups 
of individuals with distinct patterns of cognitive state changes were assigned to separate 
classes. The approaches to identify these distinct classes differ between the clinically-driven 
approach and the statistical modeling method. 
Clinically-driven approach to identify distinct patterns of cognitive state changes 
In the clinically-driven classification approach, single trajectories of cognitive state changes 
for all 574 participants were reviewed multiple times to identify different possible 
trajectories. Then, similar and dissimilar cognitive trajectories were defined based on the 
cognitive states that individuals experienced. Similarity of cognitive trajectories were defined 
based on whether individuals experienced stable or non-stable trajectories and, among non-
stable trajectories, whether they experienced a reverse transition, developed dementia or 
both. Three categories of cognitive trajectories were expected to be observed: 1) fixed-state 
trajectories: individuals who remained in the same cognitive state (i.e., normal cognition, 






reserve (i.e., reflecting stable normal cognition or cognitive improvement): for example, 
individuals who experienced some level of cognitive impairment (MCI or GI) and then 
reverted back to normal cognition; and 3) trajectories that represented progressive cognitive 
decline: for example, individuals who started with normal cognition, and then declined to 
MCI, GI, and possibly dementia. 
At this stage, the definition for the first pattern was created and the first individual was 
assigned to it. Then, the cognitive trajectory of the second individual was reviewed. If the 
cognitive trajectory of the second individual was similar to the first individual, with respect 
to stable and non-stable trajectories and reverse transition or dementia status, the second 
individual was assigned to the first pattern. However, if the cognitive trajectory of the second 
individual differed from that of the first individual, the second pattern was defined and the 
second individual was assigned to it. This process continued until all individuals were 
assigned to one pattern (see Appendix B, Table B-1 and Table B-2 for examples of similar 
cognitive trajectories across participants). The final patterns were reviewed by a geriatrician 
for clinical validation. 
Statistical modeling approach to identify distinct classes of cognitive state changes 
In the statistical modeling approach, lcmm (Proust-Lima et al., 2017) was implemented. In 
studies of longitudinal measurements of an outcome, lcmm considers both the mixed 
modeling theory that accounts for correlation between repeated longitudinal measurements 
for individuals, and the latent class modeling theory that discriminates homogeneous latent 
classes (Proust-Lima et al., 2017). The lcmm approach is particularly useful in identifying 
latent classes in longitudinal studies of aging because it is flexible in modeling unequal 
numbers of observations and different times of assessments (Proust-Lima et al., 2017).  
In the Nun Study, the number of longitudinal observations for each participant ranged 






of follow-up assessments. The time scale that accounts for the repeated measurements for 
each individual in the mixed model was age, which also controls for the effect of age on 
patterns of cognitive state changes. Both linear and quadratic terms for age were added to the 
model to allow for the quadratic changes of cognitive states with aging (Amieva et al., 2005; 
Hall, Lipton, Sliwinski, & Stewart, 2000).   
A random intercept term was added to the models to account for between-person 
heterogeneity of average cognition levels at baseline. In addition, a random slope term was 
added to the model to account for the potential variability of slope in each latent class over 
the follow-up period.   
The modeling started with fitting one latent class and then the number of latent classes was 
increased until the model fit did not improve further. Model fit was evaluated by considering 
Bayesian information criteria (BIC), posterior class-membership probabilities, and clinical 
meaningfulness of classes (Proust-Lima et al., 2017). The model with the smallest BIC, 
posterior probabilities above 0.70, and meaningful classes was chosen as the preferred 
model, and the number of classes in that model as the number of latent classes for identifying 
distinct patterns of cognitive state changes. The posterior probabilities were computed using 
Bayes theorem when the probability of belonging to each latent class is calculated given the 
available information. The mean of the posterior probabilities is the average of posterior 
probabilities for all individuals classified a posteriori in each latent class. Models with and 
without a random intercept and random slope, and with and without a quadratic term for age 
were also fitted; however, the models with a random intercept and linear and quadratic terms 
for the effect of age provided a better fit. 
For each individual, lcmm assigned membership probabilities for each class, and the class 
with the highest probability was selected as the latent class for that individual. To improve 
convergence to the global maximum likelihood of the model, the analyses were repeated 






carried out using the lcmm package (last updated on 26 June 2019) in R statistical software, 
version 3.6.1 (released on July 25, 2019). Further details about lcmm modeling are provided 
in Appendix C. The final classes of cognitive state changes were also reviewed by a 
geriatrician for clinical validation. 
Comparing results from the clinically-driven approach and the statistical modeling 
(lcmm) method 
To determine whether the two methods produced similar classes, the classes identified using 
the clinically-driven approach were compared with classes identified using the lcmm 
approach. This comparison was performed based on the number of classes, the cognitive 
states experienced within each class, whether those with and without reverse transition were 
assigned to separate classes, and whether those who did or did not develop dementia were 
assigned to separate classes. A visual representation of cognitive state changes for each of the 
classes is presented so as to provide information on approximate timing and rates of 
cognitive change and to facilitate the comparison of classes of cognitive state changes 
identified by the clinically-driven approach with those from the statistical modeling approach 
(Figure 4-2 and Figure 4-3; for more details, see Appendix D, Figure D-1 and Appendix E, 
Figure E-1). 
4.2.4 Ethics  
Ethics approval by institutional review boards was obtained from the University of Kentucky 
for the original Nun Study and from the University of Waterloo for the current study (Office 







4.3.1 Sample characteristics at baseline 
Table 4-1 illustrates the main characteristics of the analytic sample. The Nun Study 
participants were highly educated, with more than 85% having a university degree. 
 
Table 4-1 Characteristics of participants with longitudinal cognitive assessments (N = 574)    
Variables Mean (SD) Frequency (%) 
Age (years)   
     Age at first cognitive assessment 82.82 (5.16)  
     Age at last cognitive assessment 90.12 (5.35)  
Education   
     ≤ High school  83 (14.46) 
     Bachelor’s degree  235 (40.94) 
     ≥ Master’s degree  256 (44.60) 
Abbreviation: SD = standard deviation 
 
4.3.2 Patterns of cognitive state changes 
The patterns of cognitive state changes that were identified using the clinically-driven 
approach and the statistical modeling approach (lcmm) are presented below.  
4.3.2.1 Patterns of cognitive state changes identified based on the clinically-driven 
approach 
Using the clinically-driven approach, seven patterns of cognitive state changes were 






MCI or GI [N = 71, 12%], and dementia [N = 87, 15%]), and four with cognitive state 
transitions. Patterns with reverse transition(s) to better cognitive states included reversion 
without developing dementia (N = 143, 25%) and with eventual transition to dementia (N = 
37, 6%). Two patterns featured progressive cognitive decline that either did not (N = 77, 
14%) or did (N = 131, 23%) lead to dementia. Trajectories of cognitive state changes for the 
first six individuals within each of these seven patterns are presented in Figure 4-2. (All 
trajectories of cognitive state changes for the seven patterns are presented in Appendix D, 
Figure D-1.) In Figure 4-2, the seven rows represent patterns with: 1) stable normal 
cognition, 2) stable MCI or GI, 3) decline and improvement without dementia, 4) progressive 
decline without dementia, 5) decline and improvement with eventual progression to 








Figure 4-2 The first six observed trajectories from each of the seven patterns of cognitive 
state changes identified using the clinically-driven approach (overall sample N = 574)  
From top to bottom: Pattern 1) Stable normal cognition, Pattern 2) Stable mild or global impairment, 
Pattern 3) decline and improvement without dementia, Pattern 4) progressive decline without 
dementia, Pattern 5) decline and improvement with eventual progression to dementia, Pattern 6) 
progressive decline with eventual progression to dementia, and Pattern 7) stable dementia; black 
trajectories represent participants who died before the end of the data collection period; orange 
trajectories represent participants who remained alive until the end of the data collection; cognitive 






4.3.2.2 Classes of cognitive state changes identified based on the statistical modeling 
method 
The lcmm model with random intercept, age, age squared, and four latent classes had the 
smallest BIC, reasonable average posterior probabilities, and clinically meaningful distinct 
classes of cognitive state changes. The decrease in BIC from the model with four latent 
classes to the model with five classes was minor (change in BIC < 3). Therefore, the model 
with four latent classes was investigated as a potential best fit to distinguish distinct classes 
of cognitive state changes. The posterior probabilities for the model with four latent classes 
were all above 0.7 and the trajectories within each class were more similar than the 
trajectories within the other three classes. Therefore, the model with four latent classes was 
selected as the best fit to identify distinct classes of cognitive state changes. A random slope 
for cognitive trajectories over time within each latent class was also added to the model to 
account for any potential between-participant heterogeneity of change in four levels of 
cognitive states over time. However, the fit for this model was poorer than the model without 
a random slope. Therefore, the final model did not contain a random slope parameter. For 
comparison, the fitting criteria for models with a random intercept, age, and age squared, and 
different numbers of latent classes is presented in Table 4-2, and the corresponding 
distribution of participants within each class is shown in Table 4-3.  
Trajectories of cognitive state changes for the first six individuals within each of these four 
classes are presented in Figure 4-3. (All trajectories of the cognitive state changes for four 
classes are presented in Appendix E, Figure E-1.) The participants in Class 1 experienced the 
healthiest patterns of cognitive state changes until death or the end of follow-up. These 
individuals were observed with normal cognition for several years and rarely developed 
dementia. Participants in Class 2 experienced lower levels of cognition than individuals in 
Class 1, with fewer years with normal cognition and a higher proportion who developed 






dementia; however, progression to dementia happened at an older age than participants in 
Class 4. Finally, most participants in Class 4 developed dementia at a younger age than 
participants in Class 3 and lived with dementia for several years.  
 
Table 4-2 Comparison of the fitting criteria for the latent class mixed-effects modeling 
approach (with a random intercept and linear and quadratic terms for age) with different 
numbers of latent classes based on Bayesian information criterion (BIC) and average 
posterior probability in each class (N=574) 
    Average Posterior probability  
Number 













1 6 -3258.27 6554.66 1     
2 10 -3108.55 6280.63 0.82 0.86    
3 14 -3047.27 6183.47 0.85 0.76 0.79   
4 18 -3014.61 6143.57 0.82 0.73 0.78 0.72  
5 22 -3003.13 6146.02 0.83 0.72 0.74 0.72 0.68 












Table 4-3 Comparison of the distribution of participants in each class for models with 
different numbers of latent classes based on the latent class mixed-effects modeling approach 
with a random intercept and linear and quadratic terms for age (N=574) 
 Number (%) per latent class  
Number of 
classes 
Class 1 Class 2 Class 3 Class 4 Class 5 
1 574 (100%)     
2 253 (44.08%) 321 (55.92%)    
3 1536 (27.18%) 194 (33.80%) 224 (39.02%)   
4 73 (12.72%) 100 (17.42%) 210 (36.59%) 191 (33.28%)  











Figure 4-3 The first six observed trajectories from each of the four classes of cognitive state 
changes identified using the latent class mixed-effects modeling approach (overall sample N 
= 574)  
From top to bottom, Class 1 represents the healthiest trajectories of cognitive state changes and Class 
4 represents the least healthy trajectories of cognitive state changes; black trajectories represent 
participants who died before the end of the data collection; orange trajectories represent participants 
who remained alive until the end of the data collection; cognitive state 4 = normal cognition, 3 = mild 










4.3.2.3 Comparing patterns of cognitive state changes identified using two different 
approaches 
The distribution of individuals within patterns of cognitive state changes identified using the 
two methods is presented in Table 4-4. The clinically-driven approach led to seven distinct 
patterns of cognitive state changes while the lcmm approach identified four. The classes from 
the clinically-driven approach distinguished individuals who experienced reversion from 
those who did not, and also distinguished individuals who developed dementia from those 
who did not. The latent classes from lcmm could be logically ordered by the level of 
cognitive ability for participants within each latent class.  
 
Table 4-4 Distribution of individuals within patterns of cognitive state changes based on the 
clinically-driven approach among participants in each latent class based on the latent class 
mixed-effects modeling approach  
Patterns of cognitive state changes based on 
the clinically-driven approach 
Classes of cognitive state changes based on lcmm1 
Class 1 Class 2 Class 3 Class 4 Total 
1) Stable normal 16 12 0 0 28 
2) Stable MCI or GI 55 15 1 0 71 
3) Decline and improvement, no dementia  102 38 3 0 143 
4) Progressive decline, no dementia  17 43 14 3 77 
5) Decline and improvement, with dementia  9 19 8 1 37 
6) Progressive decline with dementia  11 56 45 19 131 
7) Stable dementia 0 8 29 50 87 
Total 210 191 100 73 574 
1Latent class mixed-effects modeling with four latent classes with random intercept, and linear and 
quadratic terms for age, from better cognitive function (Class 1) to worse (Class 4) 








To further compare the distinct patterns of cognitive state changes identified in the two 
methods, the overall distribution of death, the years of follow-up, and the years between last 
assessment and death for all classes were described (Tables 4-5, 4-6, and 4-7). Within each 
class, the distribution of individuals by survival status at the end of the study follow-up are 
shown in Table 4-5. Overall, 70 out of 574 participants were alive at the end of the study 
follow-up. At this time, across the seven patterns of cognitive state changes identified with 
the clinically-driven approach, none of the participants in Pattern 7 were alive. In contrast, 
32.1% of the participants in Pattern 1 remained alive. Similarly, across the four classes of 
cognitive state changes identified using the lcmm approach, none of the participants in the 




















Table 4-5 Distribution of individuals by survival status at the end of the study follow-up: (a) 
within patterns identified using the clinically-driven approach, and (b) within latent classes 
identified using the latent class mixed-effects modeling approach 
(a)  
  Observed patterns1 based on the clinically-driven approach  





































Total 28 71 143 77 37 131 87 574 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global 
impairment, Pattern 3) decline and improvement without dementia, Pattern 4) progressive decline 
without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive 
decline with dementia, Pattern 7) stable dementia 
(b)    
 Observed latent classes1 based on latent class mixed-effects modeling  

























Total 210 191 100 73 574 







The distribution of follow-up time and time from last assessment until death across classes 
is presented in Table 4-6 and Table 4-7. Participants were followed between 1.21 to 15 years. 
On average, participants were followed for 7.30 years (SD = 4.26), and average time from 
last assessment until death was 1.05 years (SD = 1.65) (Table 4-6 and Table 4-7). There is a 
time gap between the 3rd quartile for years from last follow-up until death and the maximum 
years from last follow-up until death. This longer time gap between the last assessment and 



















Table 4-6 Distribution of (a) follow-up time and (b) time from last assessment until death in 
each class identified using the clinically-driven approach  
(a) Observed patterns1 based on the clinically-driven approach  
Years of follow-up 1 2 3 4 5 6 7 Overall 
















Minimum  1.29 1.21 1.60 1.28 4.39 1.23 1.53 1.21 
1st quartile 2.63 1.67 6.00 3.37 8.60 4.46 2.39 3.38 
Median  6.46 3.11 9.83 7.10 11.68 7.18 3.47 6.82 
3rd quartile  12.13 5.64 13.42 10.11 13.94 10.89 5.76 10.94 
Maximum  14.51 14.97 15.00 14.99 15.00 14.57 11.89 15.00 
Total subsample 28 71 143 77 37 131 87 574 
(b) 
        
Years from last follow-



































Minimum  0.30 0.06 0.01 0.01 0.02 0.01 0.01 0.01 
1st quartile 0.50 0.75 0.44 0.42 0.28 0.24 0.30 0.38 
Median 0.90 1.07 0.68  0.64 0.47 0.59 0.71 0.70 
3rd quartile  1.72 1.38 1.00 1.22 0.68 0.92 1.07 1.12 
Maximum  10.14 12.43 6.67 13.39 3.82 2.15 9.43 13.39 
Deceased subsample 19 63 109 70 31 125 87 504 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global 
impairment, Pattern 3) decline and improvement without dementia, Pattern 4) progressive decline 
without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline 
with dementia, Pattern 7) stable dementia 





Table 4-7 Distribution of (a) follow-up time and (b) time from last assessment until death in 
each latent class identified using the latent class mixed-effects modeling approach 
(a) Observed latent classes1 based on latent class mixed-effects modeling  
Years of follow-up 1 2 3 4 Overall 
Mean (SD)  8.31 (4.51) 7.30 (4.26) 6.44 (3.73) 5.58 (3.38)  7.30 (4.26) 
Minimum  1.21 1.24 1.53 1.23 1.21 
1st quartile 4.29 8.13 3.12 2.89 3.38 
Median  7.98 6.93 5.48 5.29 6.82 
3rd quartile  13.02 11.03 10.07 7.61 10.94 
Maximum  15.00 15.00 14.04 13.94 15.00 
Total subsample 210 191 100 73 574 
(b) 
 
 Observed latent classes based on latent class mixed-effects modeling 
Years from last 
follow-up until death 
1 2 3 4 Overall 
Mean (SD)  1.28 (1.85) 1.06 (1.86) 0.81 (1.07) 0.85 (1.19) 1.05 (1.65) 
Minimum  0.04 0.01 0.01 0.01 0.01 
1st quartile 0.48 0.37 0.24 0.31 0.38 
Median 0.78 0.63 0.63 0.72 0.70 
3rd quartile  1.22 1.02 1.03 1.10 1.12 
Maximum  12.43 13.39 9.43 9.92 13.39 
Deceased subsample 160 173 98 73 5042 
1From better cognitive function (Class 1) to worse (Class 4) 
270 participants were alive at the time of last cognitive assessment 





Using longitudinal data from the Nun Study, this study modelled cognitive aging through 
trajectories of change across four cognitive states: normal cognition, MCI, GI, and dementia. 
Individuals were grouped into distinct patterns of cognitive state changes using two methods: 
a clinically-driven approach and a statistical modeling approach, lcmm. Using the clinically-
driven approach, trajectories of cognitive state changes in the Nun Study were clustered into 
seven distinct patterns. The lcmm approach identified four latent classes of cognitive state 
changes. The results from the clinically-driven approach were preferred for identifying 
distinct patterns of cognitive state changes. This preference was based on the higher level of 
detail in patterns captured by the clinically-driven approach compared to the latent classes 
identified using the lcmm approach. These details include distinguishing between trajectories 
with and without cognitive improvement, and with and without progression to dementia.  
Substantial heterogeneity was noted in the cognitive state trajectories in this population of 
older adults. Both methods led to a range of more to less heathy patterns. However, the 
patterns from the clinically-driven approach provided more detailed information, identifying 
reverse transitions from MCI or GI to normal cognition and distinguishing between 
trajectories that led or did not lead to dementia. Based on the results from the clinically-
driven approach, 25% of our sample experienced reversion and never developed dementia. 
Reverse transitions were from MCI or GI to normal cognition, or from GI to MCI. Only 20% 
of participants who experienced reverse transition(s) developed dementia, reflecting that 
dementia is not an inevitable cognitive state after developing MCI or even GI. This level of 
detail can only be captured by modeling approaches that are able to identify more than one 
class of cognitive changes over time and that are sensitive to distinctions between individuals 
based on whether they experienced reversion to a less impaired state or progression to 
dementia.  
The types of cognitive state changes observed in this study are consistent with those 





cognition has been noted within the Nun Study as well as other populations (Abner et al., 
2012; Iraniparast et al., 2016; Koepsell & Monsell, 2012; Malek-Ahmadi, 2016). Categories 
of cognitive decline observed using our two analytic methods were also reported in previous 
studies of transitions from normal cognition to MCI and from MCI to dementia using multi-
state Markov modeling (Kryscio et al., 2008; Riley et al., 2000; Tyas et al., 2007). In 
addition, the patterns of cognitive state changes that were identified using the clinically-
driven approach expand patterns that were reported previously by Aiken-Morgan et al. 
(2017). They identified four patterns of cognitive state changes: 1) normal cognition, 2) 
stable MCI, 3) converters from normal cognition to MCI, and 4) reverters from MCI to 
normal cognition. No progression to dementia was observed, likely due to the short follow-
up period (less than four years). However, they did confirm other reports of reversion from 
MCI, noting that 13% of their sample experienced improvement from MCI to normal 
cognition (Aiken-Morgan et al., 2017). While broadly consistent with these findings, our 
study expands their converter and reverter categories each to two patterns with or without 
progression to dementia. In addition, our study identified a pattern of stable dementia and 
expanded the stable MCI pattern to include GI. 
Other than the study by Aiken-Morgan et al. (2017), no previous study has identified 
distinct patterns of change in overall cognitive states. Similar studies that have investigated 
patterns of change within specific domains or tests that either used (Rajan et al., 2019; 
Verlinden et al., 2016) or did not use (Bretsky et al., 2003; D. Mungas et al., 2010; Wilson et 
al., 2012; Yaffe et al., 2009) lcmm modeling have reported results similar to those from our 
lcmm modeling. However, these studies and our lcmm results have been unable to identify 
the previously reported reverse transitions from cognitive impairment to normal cognition. 
Therefore, the clinically-driven approach used in our study to identify distinct patterns of 
cognitive state changes was preferred as it was able to identify both patterns of change and 
patterns with progression and reversion, and also could distinguish patterns that led or did not 





Strengths of this study include characteristics of the underlying data from the Nun Study as 
well as the analytic approach. The Nun Study is a community-based sample, which provides 
a natural cognitive trajectory based on the study design’s fixed times for cognitive 
assessments. This is in contrast to clinic-based samples, where assessments are often 
precipitated by cognitive change. In addition, the extensive longitudinal data had low levels 
of attrition and missing assessments, providing a robust data set for identifying patterns of 
cognitive state changes. Identification of two levels of cognitive impairment between normal 
cognition and dementia (MCI and GI) provided a more detailed perspective on cognitive 
trajectories than other studies, which typically have included only MCI. The homogeneity of 
the study participants controlled for many potential confounding factors; for example, 
participants were all similar in marital status, income, alcohol and tobacco use, social 
support, and access to healthcare. 
 Both analytical approaches in this study had specific strengths in identifying distinct 
patterns or classes of cognitive state changes in older adults. A strength of the clinically-
driven approach in identifying the patterns of cognitive state changes is in providing patterns 
that are more likely to be conceptually and clinically meaningful than the results of statistical 
modeling approaches, and that can be reviewed by clinicians for face validity, as was done in 
this study. When applying a clinically-driven approach to identify distinct patterns of 
cognitive state changes, other studies may use the patterns identified in this research as a 
starting point; however, the applicability of these patterns to their study populations would 
need to be confirmed, and the potential occurrence of other types of patterns not observed in 
this study also recognized. 
In contrast, a strength of the lcmm modeling approach is that it distinguishes groups of 
individuals with significantly different cognitive trajectories (latent classes), which is 
conceptually a meaningful addition to mixed modeling for which, in general, average 
trajectories are assigned to the whole sample. This statistical approach may identify these 





identified in a manual review because of the complexity of combinations. In addition, the 
lcmm approach models the actual age at cognitive assessments rather than the assessment 
time planned in the study design. This modeling approach allows inclusion of participants 
who miss follow-up assessments and is flexible enough to model ordinal longitudinal 
outcomes (Proust-Lima et al., 2017). This likelihood-based approach can model data missing 
at random and does not require data to be missing completely at random. In the Nun Study, 
similar to other studies of aging and cognition among older adults, attrition due to death is 
present; however, death in populations of older adults does not interfere with the assumption 
that data are missing at random.  
Comparing the results of the clinically-driven approach with the lcmm modeling allows for 
assessment of the performance of this statistical modeling approach in terms of its ability to 
identify meaningful patterns that are conceptually relevant in longitudinal studies of aging 
and cognition. This comparison provided knowledge on potential clinical aspects of cognitive 
trajectories that might be missed in the lcmm approach in contrast to potential factors (e.g., 
age at cognitive assessment) that cannot easily be considered in a clinically-driven approach.  
Limitations of the Nun Study in identifying patterns of cognitive state changes and in 
predicting the patterns in other populations include characteristics of the sample, study 
design, and available data. The Nun Study participants are a special population who are not 
representative of the general population of older women in the United States, and so the 
results of this study need to be interpreted accordingly. Cognitive assessments were 
performed at specific times pre-identified by study design. Therefore, cognitive states might 
have changed between two observed states (interval censoring). The Nun Study participants 
were 75+ at baseline; cognitive trajectories at younger ages thus could not be detected and 
some participants were already in the dementia state at the beginning of the study [these 
individuals were at early stages of dementia and were intact enough to consent and 
participate in the study] (left censoring). Furthermore, some participants were alive at the end 





captured (right censoring). Finally, individuals who had died with dementia and individuals 
at severe stages of cognitive impairment due to dementia at the start of the study could not be 
included in this study (left truncation). However, left truncation and right censoring may 
cancel out the effect of each other on the overall prevalence of dementia in the Nun Study. 
Furthermore, experiencing improvement from cognitive impairment to normal cognition 
might be due to treatment of factors that led to cognitive impairment, such as thyroid 
problems or other treatable factors. However, data on such interventions were not available.  
Limitations of the analytical approaches in this study vary by type of approach. Applying 
the clinically-driven method to identify an initial set of patterns was time-intensive, and the 
patterns identified in this study may differ in other data sets. However, now that these 
patterns have been identified, this clinically-driven approach can be more easily applied to 
other populations keeping in mind that modification might still be required due to differences 
across populations. The lcmm approach identified meaningful patterns of cognitive state 
changes; however, some details of trajectories that are clinically meaningful were not 
captured in the four latent classes. For example, trajectories with and without improvement to 
a higher cognitive level, or trajectories that led or did not lead to dementia are clinically 
meaningful, but were not clearly distinguished in the lcmm approach. One reason for less 
clear distinctions between diverse trajectories of cognitive state changes using the lcmm 
approach might be a low absolute fit of the model. Using BIC and the average posterior 
probabilities, the model with four latent classes was identified as a better fit than the models 
with a differing number of latent classes. The absolute fit of the model to the data set could 
not be tested due to the lack of available analytic approaches. However, a model with only a 
linear term for age was also fitted to the model and the model with both linear and quadratic 
terms for age created more clinically meaningful latent classes.  
Membership in specific patterns of cognitive state changes is clinically meaningful as it 
reflects different cognitive aging patterns and subsequent needs for care, treatment, and 





guide their prognosis, and on the frequency of reversion from a more to less impaired 
cognitive state including normal cognition, this research will benefit older adults and their 
families, and the healthcare system. Given the trend to earlier intervention for prevention of 
dementia, these results may also improve the design of clinical trials and the interpretation of 
their results, given that many individuals experience reversion from MCI or GI to normal 
cognition even without intervention. This research has identified an alternate cognitive 
outcome—membership in a pattern of cognitive state changes—to study the effect of genetic, 
environmental, psychosocial, and lifestyle factors on cognitive aging. Knowledge of 
predictors of these patterns of cognitive aging may also inform population-level interventions 
to promote healthy aging. 
In this study, patterns of cognitive state changes were identified based on one purely 
clinically-driven approach and one purely computational (statistical modeling) approach 
developed for general patterns of change in longitudinal studies. Developing a method to 
identify patterns of cognitive state changes that is more sensitive to reversion based on both 
the clinical approach and the computational method would be helpful for future research on 
cognitive aging.  
The focus of this study was on cognitive state changes to dementia; further research on 
stages of dementia would provide a more comprehensive picture of cognitive trajectories. For 
example, a study that used lcmm approach on a sample of older adults with Alzheimer’s 
disease identified three distinct patterns of cognitive decline (Geifman et al., 2018). In 
addition, future research could examine how cognitive trajectories differ among older adults 
based on type and timing of interventions. Given the time period over which the Nun Study 
population was followed in this study, interventions for cognitive impairment were limited, 
and thus this study provides information on the natural history of cognitive trajectories. 
These trajectories are relevant particularly when interventions are not possible or feasible due 
to financial constraints, other health conditions, or when interventions do not help to modify 





aging in other populations and to identify predictors of membership in these patterns to target 
interventions of modifiable risk factors to support healthy cognitive trajectories.  
In this research, the association of brain pathology with the patterns of cognitive state 
changes was not studied. For example, some participants in the pattern with progressive 
cognitive decline with dementia experienced rapid decline from normal cognition to 
dementia, which could be due to delirium or stroke. In a study of 1096 older adults with 
annual cognitive assessments for up to 21 years and brain donation, several pathological 
factors such as Alzheimer’s pathology, vascular pathologies, and Lewy bodies were 
associated with cognitive trajectories. However, their effects of these pathologies on 
cognitive trajectories differed. For example, Alzheimer’s pathology was associated with 
progressive cognitive decline, but atherosclerosis was associated with lower overall cognitive 
performance with a relatively stable trajectory (Boyle et al., 2017).        
Overall, the trajectories of cognitive aging seen in this study were heterogeneous and 
included substantial proportions of older adults in trajectories reflecting cognitive 
improvement, even in this very old population. A possible explanation for this heterogeneity 
in patterns of cognitive state changes includes intellectual and genetic factors, which are 





The Association of Academic Achievement with Patterns of Cognitive State 
Changes 
5.1 Introduction  
With the global population of older adults increasing, the prevalence of age-related 
conditions such as dementia is also increasing across the world. In 2010, the prevalence of 
dementia was 36 million, and this number is expected to increase to 66 million cases by 2030 
and to 115 million cases by 2050 (Ferri et al., 2005; Prince et al., 2013). Dementia is among 
the top ten conditions contributing to increased years lived with disability among older adults 
(Prince et al., 2015). On the other hand, healthy cognitive aging is associated with well-being 
and health-related quality of life among older adults (Davis et al., 2015).  
More years of education are known to be associated with cognitive reserve—that is, when 
Alzheimer’s pathology is present, those with higher education may not develop the clinical 
signs of dementia typically associated with this pathology, or may develop it later, compared 
to individuals with lower education (Y. Stern et al., 1999). In addition, longitudinal studies of 
aging and cognition have observed that higher educational attainment is associated with 
potential cognitive reserve as shown through four categories of evidence: 1) higher cognitive 
performance upon reaching older adulthood (Alley et al., 2007; McDermott et al., 2016; D. 
Mungas et al., 2018; Tucker-Drob et al., 2009; Wilson et al., 2019; Zahodne et al., 2015); 2) 
slower cognitive decline compared to older adults with lower educational attainment (Alley 
et al., 2007; McDermott et al., 2016; Reas et al., 2017; Zahodne et al., 2015); 3) delayed 
accelerated decline (when clinical diagnosis of dementia occurs at an older age for 
individuals with higher than with lower educational attainment, but once reserve is exhausted 
and decline begins, this decline is faster in those with higher educational attainment) (Castro-
Costa et al., 2011; Clouston et al., 2019; Hall et al., 2007; Wattmo et al., 2014); and 4) 
greater probability of reversion from mild cognitive impairment (MCI) to normal cognition 





have found that higher educational attainment does not slow cognitive decline (Karlamangla 
et al., 2009; D. Mungas et al., 2018; Muniz-Terrera et al., 2009; Tucker-Drob et al., 2009; 
Wilson et al., 2019; Zahodne et al., 2011), their results cannot be interpreted as effectively 
contradicting the theory of cognitive reserve for the effect of education on cognitive aging 
because methodologic issues such as their analytic approach may have led to the observed 
non-significant association between higher education and slower rate of cognitive decline. 
The first three categories of evidence on how educational attainment is associated with 
cognitive reserve among older adults modeled cognition through temporal cognitive 
trajectories; however, they did not identify whether individuals with higher levels of 
education experienced cognitive improvement (i.e., reversion to a less impaired state). On the 
other hand, although reversion has been investigated in the fourth category of evidence, these 
studies do not model temporal cognitive trajectories for individuals who experience reverse 
transitions, such as whether those who experience reverse transitions eventually develop 
dementia.  
Our previous work on patterns of cognitive state changes among older adults addressed 
these gaps by combining both temporality and reversion (see Chapter 4) and sets the stage to 
examine predictors of these patterns. In addition, little is known about the impact of measures 
of academic achievement beyond education on late-life cognition. The aim of this study was 
to identify the association of academic achievement (educational attainment and academic 
performance) with temporal patterns of cognitive state changes.   
5.2 Methods 
5.2.1 Sample  
This study is based on secondary data from the Nun Study, a longitudinal cohort study of 
aging and cognition. The participants are American members of a religious congregation, the 
School Sisters of Notre Dame. Between 1991 and 1993, all members who were 75 years or 





invited to join the Nun Study (N=1,031), and 678 (66%) volunteered to participate. These 
volunteers did not differ significantly from nonparticipants in their average age at baseline, 
mortality rate, race, and country of birth (Snowdon et al., 1996). 
Individuals needed to have at least one follow-up after their baseline assessment to be 
included in the longitudinal data analysis (n=574) (Figure 5-1). More than 87% (n = 504) of 
the participants were followed until death. The remaining 70 individuals were alive at the end 
of the assessment period, and thus their complete cognitive trajectories until death were not 
observed. 
The sample was further restricted to exclude those with missing data on APOE status (n = 
31) (Figure 5-1). Different subsamples of the remaining 543 individuals had complete data 
on academic performance in first-year high school English (n = 401), Latin (n = 368), algebra 
(n = 400), and geometry (n = 385). For a subsample of 411 participants, a grade was 



















Figure 5-1 Derivation of analytic sample for testing the association of academic achievement with patterns of cognitive state changes
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Data sources from young adulthood, middle adulthood, and late life and death were available 
from archival records, annual cognitive and physical assessments, and genotyping.  
5.2.2.1 Exposure factors  
The convent archives provided a source of early-life data, including measures of academic 
achievement such as overall educational attainment and academic performance in high 
school. Highest level of education attained was categorized as grade school, high school, 
Bachelor’s degree, and Master’s degree or higher. Final grades for the four most common 
courses (English, Latin, algebra, and geometry) were extracted from high school transcripts. 
For participants whose transcripts were available (n=411), missing grades reflect that the 
participant did not take that course in high school (Figure 5-1). Academic performance in 
each of the high school courses was treated as a continuous variable with a possible range of 
0 to 100%, and was coded to determine the effect of each 10% increase in the final grade 
(i.e., from 70% to 80%) on patterns of cognitive state changes later in life. Overall academic 
performance was measured based on an average of the grades available for one or more of 
the four courses (grade point average [GPA]). 
5.2.2.2 Outcome 
The longitudinal data on cognitive states were used to identify the patterns of cognitive state 
changes. These longitudinal data were based on approximately annual cognitive assessments 
from 1991 until death or the end of the 12th round of assessments. Surviving participants at 
each assessment were assigned into four mutually exclusive cognitive states: 1) normal 
cognition; 2) MCI; 3) global impairment (GI); or 4) dementia. These assessments over time 
produce a sequence of longitudinal ordinal outcomes for each participant that we call a 
cognitive trajectory. The criteria assigning individuals to these cognitive states have been 
described previously (Riley et al., 2002; Snowdon et al., 1996; Tyas et al., 2007) and are 





Normal cognition. Participants with normal cognition had intact cognition in four cognitive 
tests (Riley et al., 2002) in the neuropsychological battery of the Consortium to Establish a 
Registry for Alzheimer's Disease (CERAD) (≥14 for Boston Naming, ≥12 for Verbal 
Fluency, ≥5 for Delayed Word Recall, and ≥9 for Constructional Praxis) (Morris et al., 1989; 
Welsh et al., 1994), intact global cognition based on the MMSE (≥24) (Folstein et al., 1975), 
and intact function in at least four out of five performance-based ADL (i.e., feeding, 
dressing, walking, standing [transferring], and toileting) (Kuriansky & Gurland, 1976; Potvin 
et al., 1972). 
Mild cognitive impairment. Participants with MCI were diagnosed based on having at least 
one specific area of impaired cognition (e.g., memory or naming) based on four cognitive 
tests from the CERAD neuropsychological battery, but with intact global cognition based on 
the MMSE (≥24), intact function in at least four out of five performance-based ADL, and not 
meeting criteria for dementia (Kuriansky & Gurland, 1976; Potvin et al., 1972). The cut-off 
point used for impairment in each test was 1.5 standard deviations below age-appropriate 
means, consistent with established definitions (Petersen et al., 1997; Petersen et al., 1999; 
Petersen, 2011; Smith et al., 1996). 
Global impairment. Participants with GI were diagnosed based on having impairment in 
global cognitive function (MMSE < 24), in performance-based ADL, or both. They were also 
impaired in at least one out of four tests from the CERAD neuropsychological battery. 
However, participants with GI did not meet criteria for dementia because if they had 
impairment in two areas of cognition, they were intact for performance-based ADL (≥4) 
(Riley et al., 2002; Riley et al., 2005). 
Dementia. For a diagnosis of dementia, a participant had to have an impairment in memory 
and in at least one other cognitive domain based on the CERAD neuropsychological battery, 
impairment in performance-based ADL, and a decline from previous cognitive level 




using scores below the 5th percentile of age norms in the CERAD battery (Morris et al., 1989; 
Welsh et al., 1994). 
5.2.2.3 Covariates 
Age at each cognitive assessment was calculated by subtracting the birth date from the 
assessment date. APOE status of the participants was identified using genetic material from 
buccal cells collected from living individuals or from cadaveric brain specimens using 
methods described previously (Mortimer, Snowdon, & Markesbery, 2009; Saunders et al., 
1996). Participants with at least one ε4 allele were classified as APOE-ε4 carriers.  
5.2.3 Analysis 
Participants were assigned to one of the seven patterns of cognitive state changes using a 
clinically-driven approach, with details on the grouping procedure described previously 
(Chapter 4, Section 4.2.3). In brief, these patterns were defined based on whether individuals 
experienced stable or non-stable trajectories and, among non-stable trajectories, whether they 
experienced a reverse transition to a less impaired state, whether they developed dementia, or 
both.  
For bivariate analysis, the average of each continuous covariate was compared across the 
seven patterns using analysis of variance (ANOVA) and, when the assumptions for 
ANOVA—equality of variances or normal distribution for residuals—were not observed, 
using Kruskal-Wallis rank sum testing. For categorical covariates, the proportion of 
observations was compared across the seven patterns using a chi-square test. When more 
than 20% of cells in the contingency table had expected frequencies of less than 5, 
multinomial logistic bias reduction regression modeling of that categorical variable alone 
was used as Fisher’s exact test did not converge given the extensive possible combinations of 





Multinomial logistic bias reduction regression modeling (I. Kosmidis & Firth, 2011) was 
applied to identify the association between academic achievement and membership in 
patterns of cognitive state changes, with membership in the most impaired pattern (stable 
dementia) used as the reference category. Regular multinomial logistic regression (without 
bias reduction) could not estimate the odds ratio and its corresponding 95% confidence 
interval for the association between educational attainment and membership in Pattern 1 
versus Pattern 7 due to sparsity issues; specifically, there was no one with high school or 
lower educational attainment in Pattern 1. Multinomial logistic bias reduction regression 
modeling extends Firth regression (Firth, 1993) for reduced-bias estimation in full 
exponential family models using a computationally efficient approach (I. Kosmidis & Firth, 
2011). This updated model can estimate odds ratios and their corresponding confidence 
intervals for all levels of exposure even when some levels of exposure have zero observations 
in some levels of the outcome variable. Goodness of fit for the multinomial logistic 
regression models was tested using the Hosmer-Lemeshow test (Fagerland, Hosmer, & 
Bofin, 2008). 
All analyses were performed using the statistical software package R (version 3.6.1). For 
the bivariate analyses, ANOVA was performed using the aov function, the Kruskal-Wallis 
rank sum testing was performed using the kruskal.test function, and the chi-square test was 
performed using the chisq.test function. The brmultinom function from the brglm2 package 
(I. Kosmidis, Pagui, & Sartori, 2018) was used for fitting multinomial logistic regression 
models with bias reduction analyses; the logitgof function from the generalhoslem package 
was used for checking the goodness of fit of these models (Jay, 2019). 
5.2.4 Ethics 
Ethics approval by institutional review boards was obtained from the University of Kentucky 
for the original Nun Study and from the University of Waterloo for the current study (Office 





Baseline mean age, APOE-ε4 status and educational attainment differed significantly among 
participants across the seven patterns of cognitive state changes (Table 5-1). Participants in 
Pattern 1 and Pattern 7 were the youngest and oldest individuals respectively. Participants 
who experienced cognitive decline and improvement without dementia (Pattern 3) had the 
lowest proportion of APOE-ε4 carriers followed by participants who experienced stable 
normal cognition (Pattern 1) and participants who experienced cognitive decline and 
improvement with eventual progression to dementia (Pattern 5).      
Overall, more than 85% of the Nun Study participants had completed postsecondary 
education. All participants who experienced stable normal cognition (Pattern 1) had 
postsecondary education, and more than 80% had earned a graduate degree, the highest 
percentage of any of the patterns. Graduate-level education was also the most common level 
of education for participants who experienced reverse transitions to higher cognitive levels 
(Patterns 3 and 5). Similarly, the proportion of participants with graduate education was 
lowest for those with stable dementia (Pattern 7). The average grades in each course and the 
overall GPA did not differ significantly across patterns of cognitive state changes within any 
of the subsamples (see Table 5-1 for GPA subsample and Appendix F, Tables F-1 to F-5 for 
additional tables for subsamples for individual courses and for GPA).   
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Table 5-1 Characteristics of participants within patterns of cognitive state changes (N = 411) 
 
 Patterns1 of cognitive state changes  
Characteristics 1 2 3 4 5 6 7 Total 
Mean age, years (SD)  78.32 (1.91) 83.16 (4.73) 80.97 (4.32) 81.99 (4.36) 82.91 (5.68) 83.55 (5.16) 86.13 (5.40)*** 82.64 (5.09) 
APOE-ε4 allele, n (%)          
     Present 2 (10.53) 7 (20.00) 11 (9.82) 14 (23.73) 5 (16.13) 31 (30.69) 19 (35.19) 89 (21.65) 
     Absent 17 (89.47) 28 (80.00) 101 (90.18) 45 (76.27) 26 (83.87) 70 (69.31) 35 (64.81)** 322 (78.35) 
Education, n (%)         
     ≤ High school 0 (0.00) 1 (2.86) 4 (3.57) 1 (1.69) 2 (6.45) 7 (6.93) 9 (16.67) 24 (5.84) 
     Bachelor’s degree 3 (15.79) 18 (51.43) 45 (40.18) 29 (49.15) 14 (45.16) 50 (49.50) 32 (59.26) 191 (46.47) 
     ≥ Master’s degree 16 (84.21) 16 (45.71) 63 (56.25) 289 (49.15) 15 (48.39) 44 (43.56) 13 (24.07)* 196 (47.69) 
Academic performance         
     GPA, mean (SD) 86.35 (6.75) 88.25 (5.70) 86.97 (6.63) 88.38 (5.46) 86.18 (5.62) 86.14 (6.37) 85.88 (6.35) 86.85 (6.25) 
Total sample 19 35 112 59 31 101 54 411 
Deceased, n (%) 13 (68.42) 33 (94.29) 87 (77.68) 54 (91.53) 25 (80.65) 98 (97.03) 54 (100) 364 (88.56) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement 
without dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive 
decline with dementia, Pattern 7) stable dementia 
Abbreviations: APOE-ε4 = apolipoprotein E-ε4; GPA = grade point average; SD = standard deviation 










Adjusting for age and APOE, higher levels of education (Master’s degree or higher) were 
associated with higher odds of experiencing three healthier patterns of cognitive state 
changes (Patterns 3, 4 [cognitive decline without dementia], or 6 [delayed onset for those 
who developed dementia]) versus the reference category of stable dementia (Pattern 7) 
(Table 5-2). These associations were slightly different for the subsample with available 
grades for English, algebra, and geometry, where attaining a graduate degree was associated 
with experiencing Patterns 3 or 4 versus stable dementia (Appendix G, Tables G-1, G-3, and 
G-4) and very different for the subsample with available grades for Latin, where higher 
educational attainment was not associated with experiencing healthier patterns (Appendix G, 
Table G-2). In addition, in these fully adjusted models, the covariates age and APOE were 
significantly associated with cognitive state patterns. Compared to the reference category of 
stable dementia (Pattern 7), older age was associated with lower odds of experiencing 
healthier patterns of cognitive state changes (Patterns 1, 3,4, 5, or 6) while carrying an 
APOE-ε4 allele was associated with lower odds of experiencing Patterns 1, 2, 3, 4, or 5 
(Table 5-2).   
In models of academic performance adjusted for age and APOE, each additional 10% 
increase in GPA was significantly associated with higher odds of experiencing the patterns of 
stable MCI or GI (Pattern 2) or progressive decline without dementia (Pattern 4) versus the 
pattern of stable dementia (Pattern 7) (Table 5-3). This association between GPA and 
patterns of cognitive state changes was mostly due to the association with performance in 
algebra: after repeating analyses for the four courses individually, only higher performance in 
algebra was significantly associated with experiencing Patterns 2 or 4 versus Pattern 7, with 
this significant association not observed for other courses (Appendix H, Tables H-1 to H-4).  
In addition, in the fully adjusted model, the covariates age and APOE were significantly 
associated with cognitive state patterns. Compared to the reference category of stable 
dementia (Pattern 7), older age was associated with lower odds of experiencing all healthier 
patterns of cognitive state changes (Patterns 1, 2, 3,4, 5, or 6) and carrying an APOE-ε4 allele 
was associated with lower odds of experiencing Patterns 1, 3, or 5 (Table 5-3). Overall, the 
goodness of fit for all models was not rejected. 
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Table 5-2 The association of educational attainment with membership in patterns of cognitive state changes (N = 411) 
 Pattern1 1 vs 7 Pattern 2 vs 7 Pattern 3 vs 7 Pattern 4 vs 7 Pattern 5 vs 7 Pattern 6 vs 7 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Unadjusted       
Education  
(vs. ≤ high school) 
      
      Bachelor’s degree 2.05 (0.08–52.31) 3.61 (0.52–24.87) 2.96 (0.82–10.67) 5.75 (0.85–38.85) 1.70 (0.34–8.54) 1.97 (0.64–6.02) 
      ≥ Master’s degree 23.22 (1.02–530.91) 7.74 (1.07–56.12) 9.93 (2.06–37.88) 13.84 (1.96–97.71) 4.36 (0.83–23.02) 4.18 (1.26–13.79) 
Adjusted for age and APOE      
Education  
(vs. ≤ high school) 
      
      Bachelor’s degree 3.10 (0.10–95.56) 3.68 (0.53–25.61) 3.26 (0.80–13.33) 5.76 (0.82–40.66) 1.76 (0.34–9.08) 1.92 (0.61–6.02) 
      ≥ Master’s degree 19.81 (0.71–551.79) 6.81 (0.91–50.94) 7.89 (1.81–34.45) 10.69 (1.43–79.80) 3.85 (0.69–21.41) 3.53 (1.02–12.27) 
       
Age (years) 0.64 (0.52–0.78) 0.91 (0.84–1.00) 0.82 (0.76–0.89) 0.87 (0.80–0.94) 0.91 (0.83–0.99) 0.93 (0.87–0.99) 
       
APOE-ε4 carrier 
(vs. non-carrier) 
0.15 (0.03–0.68) 0.34 (0.12–0.95) 0.13 (0.05–0.32) 0.39 (0.16–0.93) 0.27 (0.09–0.82) 0.61 (0.29–1.29) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement 
without dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive 
decline with dementia, Pattern 7) stable dementia 












Table 5-3 The association of average performance in four high school courses with membership in patterns of cognitive state changes 
(N = 411) 
 Pattern1 1 vs 7 Pattern 2 vs 7 Pattern 3 vs 7 Pattern 4 vs 7 Pattern 5 vs 7 Pattern 6 vs 7 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Unadjusted        
GPA2 1.10 (0.49–2.48) 1.85 (0.91–3.76) 1.31 (0.79–2.20) 1.94 (1.05–3.58) 1.07 (0.54–2.12) 1.07 (0.64–1.79) 
Adjusted for age and APOE        
GPA 1.41 (0.60–3.28) 2.12 (1.02–4.41) 1.58 (0.90–2.78) 2.29 (1.20–4.36) 1.23 (0.60–2.51) 1.20 (0.70–2.07) 
Age at first assessment (years) 0.61 (0.50–0.75) 0.89 (0.82–0.96) 0.80 (0.74–0.86) 0.84 (0.78–0.91) 0.88 (0.81–0.96) 0.91 (0.86–0.97) 
APOE-ε4 carrier (vs. non-carrier) 0.17 (0.04–0.75) 0.38 (0.14–1.05) 0.15 (0.06-0.36) 0.44 (0.18–1.04) 0.29 (0.10–0.90) 0.67 (0.32–1.39) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement 
without dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive 
decline with dementia, Pattern 7) stable dementia 
2categorization of overall academic performance across up to four courses measured in 10% categories 








Higher academic achievement, as evidenced by educational attainment or performance in 
high school courses, is associated with cognitive reserve. Adjusting for age and APOE, 
higher education (i.e., a graduate degree) was associated with patterns of cognitive decline 
without dementia (with or without reversion to a higher cognitive level) or delayed onset of 
dementia. Higher overall academic performance was significantly associated with 
experiencing stable cognitive impairment or cognitive impairment without dementia. This 
association between higher overall academic performance and healthier patterns of cognitive 
state changes was mostly due to the significant association with higher performance in 
algebra. Adjusting for academic achievement, younger age and absence of an APOE-ε4 allele 
were significantly associated with experiencing healthier patterns of cognitive state changes. 
The results of this study suggest that academic achievement can contribute to cognitive 
reserve through four categories of evidence: 1) better cognitive performance upon reaching 
older age; 2) slower rate of cognitive decline; 3) delayed onset of dementia or delayed 
accelerated decline; and 4) reversion from a more to less impaired cognitive state.  
First, this study found that adjusting for age, higher academic achievement increased the 
odds of experiencing patterns of cognitive state changes (Patterns 2, 3, 4, and 6) without 
dementia at baseline (75+ years) and thus reflected a higher cognitive level upon reaching 
older age than the pattern of stable dementia (Pattern 7), where individuals already had 
dementia at baseline. This finding is consistent with previous research that found higher 
educational attainment was associated with better cognitive performance upon reaching 
adulthood or older age (Alley et al., 2007; McDermott et al., 2016; D. Mungas et al., 2018; 
Y. Stern et al., 2018; Tucker-Drob et al., 2009; Wilson et al., 2019; Zahodne et al., 2015).  
Second, this study also found that adjusting for age, higher academic achievement 
increased the odds of experiencing three distinct patterns of cognitive state changes (Patterns 
2, 3, and 4) that did not lead to dementia compared to the reference pattern of stable 
dementia. Therefore, individuals in these three patterns had a slower cognitive decline that 




cognitive decline has also been reported previously (Alley et al., 2007; McDermott et al., 
2016; Reas et al., 2017; Zahodne et al., 2015). 
Third, for those individuals who did progress to dementia, higher educational attainment 
was found to increase the odds of experiencing a pattern with fewer years with dementia 
(Pattern 6) versus more years with dementia (Pattern 7) after adjusting for age, reflecting 
delayed onset of dementia. In addition, higher academic achievement that increased the odds 
of experiencing trajectories of cognitive decline without dementia (Patterns 2, 3, or 4) versus 
the pattern of stable dementia may reflect even longer delays to onset of dementia leading to 
cognitive impairment that did not progress to dementia by the time of death. Similar effects 
of delays in progressive cognitive decline were observed in previous research through 
delayed accelerated decline (Clouston et al., 2019; Hall et al., 2007; Y. Stern et al., 2018).      
Fourth, higher educational attainment distinguished membership in a pattern of cognitive 
decline and improvement (Pattern 3) from a pattern of stable dementia (Pattern 7). This 
supports previous research that higher educational attainment builds cognitive reserve that 
may lead to reverse transitions from MCI to normal cognition (Canevelli et al., 2016; 
Sachdev et al., 2013; Xue et al., 2019). Sachdev et al., (2013) observed that reverters had on 
average one more year of education than non-reverters (12.3 vs. 11.2 years), consistent with 
our findings. In their sample, however, the average level of education was lower than that of 
the Nun Study. Our study showed beneficial cognitive outcomes for a more highly educated 
cohort, which may be more typical of future aging cohorts.  
In addition to this evidence linking reversion to cognitive reserve, a higher level of reserve 
would be present if individuals with higher educational attainment had higher odds of 
experiencing stable normal cognition versus stable dementia (i.e., remaining in the normal 
cognitive state rather than experiencing MCI and then improving to normal cognition). 
However, in this study, higher educational attainment was not significantly associated with 
higher odds of experiencing the pattern of stable normal cognition than that of stable 
dementia. This may be because the level of reserve conferred by higher educational 




power issue as all individuals with stable normal cognition had a university degree and small 
cell sizes across all levels of education among participants with stable normal cognition 
meant that there was reduced precision of estimates and less power to detect a significant 
association. Among those showing a stable normal cognition pattern, the younger average 
age and higher proportion of individuals who remained alive at the end of the data collection 
may also have contributed to the lack of a significant association, as their cognitive 
trajectories could have eventually changed if they were followed until death. In contrast, the 
observed association between educational attainment and patterns of cognitive state changes 
in this study cannot be due to higher income among those with higher education, as has been 
noted by others (Zahodne et al., 2015), because Nun Study participants are homogeneous 
with respect to income: they do not support themselves through individual incomes but 
instead are supported by the religious order.    
Algebra was the only course where higher performance increased the odds of experiencing 
healthier patterns of cognitive state changes versus stable dementia. This association may 
reflect a specific connection of math abilities with cognitive reserve, as has been previously 
reported (Arcara et al., 2017). Our study suggests that an association between math abilities 
and cognitive reserve might vary by type of math, and be more strongly related to abilities in 
algebra rather than geometry. In contrast, language abilities as measured by academic 
performance in English and Latin were not associated with healthier patterns of cognitive 
aging. However, other aspects of language ability as measured by bilingualism (Antoniou & 
Wright, 2017) or multilingualism (Hack, Dubin, Fernandes, Costa, & Tyas, 2019) have been 
shown to promote healthier cognitive aging.  
In a study of individuals with MCI in the Nun Study, those with higher educational 
attainment and higher performance in high school English were more likely to improve from 
MCI to normal cognition than progress from MCI to dementia (Iraniparast et al., 2016). 
However, in that study the participants with stable dementia (the reference pattern of 
cognitive state changes in the current study) were excluded as they had already developed 




addition, that study did not distinguish the two predementia cognitive states used in this study 
(MCI and GI) and thus improvements from GI to MCI were not modeled.    
Strengths of this study include characteristics of the underlying data from the Nun Study as 
well as the analytic approach. The Nun Study is a community-based (as opposed to a clinic-
based) sample, which provides a natural cognitive trajectory based on the study design’s 
fixed times for cognitive assessments (vs. need-based cognitive assessments in clinical 
records of cognitive assessments). In addition, the extensive longitudinal data had low levels 
of attrition and missing assessments, providing a robust data set for identifying patterns of 
cognitive state changes. Identification of two levels of cognitive impairment between normal 
cognition and dementia (MCI and GI) provided a more detailed perspective on cognitive 
trajectories than other studies that typically include only MCI. Archival data on academic 
performance allowed investigation of less frequently studied measures of early-life academic 
achievement. Genotyping allowed for adjustment by APOE status. The homogeneity of the 
study participants controlled for many potential confounding factors: for example, 
participants were all similar in marital status, income, social support, alcohol and tobacco 
use, and access to healthcare. 
Strengths of our analytic approach include identifying multiple patterns of cognitive state 
changes, thus providing an appropriate perspective for studying cognitive trajectories. A 
strength of the approach used to identify the patterns of cognitive state changes is that it 
distinguishes groups of individuals with different cognitive trajectories, which are 
conceptually a meaningful addition to modeling approaches that assign one average pattern 
to the whole sample. These patterns were determined to be preferable to an alternative set 
identified using latent class mixed-effects modeling (see Chapter 4). In addition, bias 
reduction multinomial logistic regression models were used to model the association between 
covariates and patterns of cognitive state changes. This analytic method is able to estimate 
point estimates (ORs) and their corresponding confidence intervals for all levels of exposure 
and outcome even when no observations were available for some categories. However, using 




zero or few observations has limitations: these estimations are less meaningful and 
interpretable due to wide confidence intervals. The goodness of fit for all multinomial models 
was not rejected; however, statistically, the validity of these tests in the presence of sparse 
observations needs to be checked in future research.    
Limitations of the Nun Study include that its participants are a special population of 
women with very similar lifestyles who are not representative of the general population of 
older women in the United States, and the results of this research need to be interpreted 
accordingly. On the other hand, the results of this research on the Nun Study represent the 
potential possibilities of healthier cognitive aging in a special population who implements 
many of the protective factors (e.g., high educational attainment and academic performance, 
and high social support) and avoids many of the risk factors (e.g., tobacco and excessive 
alcohol use) for healthy cognitive aging. Participants of the Nun Study are generally well 
educated, and their level of education is more similar to the future generation of older women 
than the general population of women in their birth cohort who experienced educational 
disadvantages (Bonaiuto et al., 1995; Launer et al., 1999). In population studies of the 
association between education and cognition among older adults 70 and older, the effect of 
education on cognitive reserve was only observed in men (Mielke, Vemuri, & Rocca, 2014). 
However, in the Nun Study’s all-female population, a significant association between higher 
educational attainment and cognitive reserve was observed.  
Cognitive assessments were performed at specific times, pre-identified by the study design 
to be approximately one year apart. Therefore, cognitive states might have changed and then 
reverted between two assessments and this intervening change would not have been detected. 
In addition, the Nun Study participants were 75+ at baseline. Therefore, cognitive trajectories 
before this age could not be detected, and some participants were already in the dementia 
state at the beginning of the study. Finally, at the end of the cognitive assessment follow-up 
period, 70 participants were alive and their future cognitive trajectories were not known.  
Despite the limitations mentioned above, this study contributes to our understanding of 




achievement” that goes beyond educational attainment and includes levels of academic 
performance across different subjects suggests that reaching for higher academic 
achievement either through higher educational attainment or academic performance may 
contribute to cognitive reserve and healthier cognitive aging. The significant association 
between high school algebra grades and pattern of cognitive state changes suggests that, 
beyond the overall level of education attained, the quality of performance in specific courses 
earlier in life may affect patterns of cognitive trajectories later in life. Higher academic 
achievement can contribute to building cognitive reserve through higher cognitive levels 
upon reaching older age, a slower rate of cognitive decline, reversion to a higher cognitive 
level after showing signs of impairment, and, when dementia does occur, a delay in its onset. 
Understanding the association between academic achievement and patterns of cognitive state 
changes has implications for developing strategies to build cognitive reserve and promote 
















The Effect of Apolipoprotein E on Educational Attainment Earlier in Life 
and on Patterns of Cognitive State Changes Later in Life: Testing the 
Antagonistic Pleiotropy Hypothesis 
6.1 Introduction 
Apolipoprotein E (APOE) is the most significant genetic risk factor for Alzheimer’s disease, 
the most common type of dementia. Previous research on the effect of APOE on cognition 
earlier and later in life has suggested that the APOE-ε4 allele may be associated with higher 
cognitive abilities earlier in life, but with cognitive decline and dementia later in life. In 
children and young adults, APOE-ε4 has been associated with better performance in 
cognitive abilities such as infant development (Wright et al., 2003), visuospatial processing 
(Bloss et al., 2010), verbal fluency (Marchant et al., 2010), decision making (Marchant et al., 
2010), performance on neuropsychological tests (Han & Bondi, 2008), IQ scores (Yu et al., 
2000), and educational attainment (Hubacek et al., 2001). However, other studies have not 
found this beneficial effect of APOE-ε4 on cognition earlier in life (Bretsky et al., 2003; 
O'Donoghue et al., 2018). In contrast, the adverse effect of APOE-ε4 on higher risk and 
earlier onset of Alzheimer’s disease is observed consistently across studies and populations 
(Corder et al., 1993; Spinney, 2014). APOE-ε4 is also associated with an increased risk of 
vascular dementia (Chuang et al., 2010), all-cause dementia (Llewellyn et al., 2010), and 
cognitive decline among older adults without dementia (Han & Bondi, 2008).  
In the field of evolutionary biology, this beneficial effect of a genetic allele earlier in life 
contrasted with its adverse effects later in life is termed antagonistic pleiotropy, a concept 
proposed in the 1950s by Medawar (1952) and Williams (1957). With increases in life 
expectancy of humans well beyond the reproductive period, genes with a potential 
antagonistic pleiotropy effect now have more time to exert their detrimental effects later in 
life. Therefore, studying the potential antagonistic pleiotropy effect of genes in humans is 




investigated the effects of APOE-ε4 on cognition in separate samples of younger and older 
individuals, the ε4 allele of the APOE gene has been suggested to have an antagonistic 
pleiotropy effect on cognition (Alexander et al., 2007; Tuminello & Han, 2011; Wright et al., 
2003).  
Tuminello & Han (2011) also suggested that because there is evidence to support 
beneficial effects of the APOE-ε4 allele during childhood and young adulthood in addition to 
detrimental effects during older adulthood, assessing the interaction between age and APOE-
ε4 when studying the effect of APOE-ε4 on cognition may be a valuable addition to 
investigations of antagonistic pleiotropy. However, when the effect of APOE-ε4 on cognition 
earlier in life and later in life is assessed on separate samples, as has been done in previous 
studies (Corder et al., 1993; Spinney, 2014; Wright et al., 2003), this interaction cannot be 
tested. One study that investigated the effect of APOE-ε4 on cognition earlier and later in life 
in the same cohort did not find a significant association between APOE-ε4 and their measure 
of cognitive abilities in early life (IQ). However, they reported that APOE-ε4 was associated 
with lower nonverbal cognition in old age (Luciano et al., 2009). Their analysis for the 
association between APOE-ε4 and cognition earlier and later in life thus found an interaction 
between age and APOE, when the effect of APOE on cognition depended on age group.  
 The scaffolding theory of aging and cognition (Park & Reuter-Lorenz, 2009; Reuter-
Lorenz & Park, 2014) is a complementary theory to the antagonistic pleiotropy theory. The 
scaffolding theory implies that APOE-ε4 carriers who had benefited from the potential 
positive effect of APOE-ε4 on cognition earlier in life may develop cognitive reserve that 
will compensate for the detrimental effect of APOE-ε4 on late-life cognition, such that their 
risk of dementia would be similar to APOE-ε4 non-carriers. Thus far, several studies have 
found that higher educational attainment earlier in life could modify the detrimental effect of 
APOE-ε4 on cognition later in life (Arenaza-Urquijo et al., 2015; Reas et al., 2019; Tyas et 
al., 2007), although this is not universally reported (Ngandu et al., 2007). It has also been 
suggested that such an interaction may only be present among men (Hasselgren et al., 2019). 




APOE-ε4 on cognition among older adults, these studies have not determined whether 
APOE-ε4 is also associated with higher educational attainment earlier in life within the same 
sample. Therefore, evidence is lacking on the interaction between age (i.e., early life and late 
life) and APOE, and its impact on cognition. 
One reason for the importance of identifying the association between APOE and cognition 
with aging is that APOE is a new target for developing treatments and yet its effect on 
cognition with aging is unclear (Bales & Paul, 2019; Safieh et al., 2019; Uddin et al., 2019). 
The aim of this study was to test the antagonistic pleiotropy effect of APOE-ε4 on cognition 
by: 1) investigating the association of APOE-ε4 with educational attainment earlier in life; 2) 
investigating the association of APOE-ε4 with patterns of cognitive state changes later in life; 
and 3) determining if educational attainment modifies the association between APOE status 
and patterns of cognitive state changes later in life.  
6.2 Methods 
6.2.1 Sample  
The details of the Nun Study and the analytic sample for cognitive trajectories are presented 
in the sample section of Chapter 4 (Section 4.2.1, and duplicated in the first two paragraphs 
below).  
This research is based on secondary data from the Nun Study, a longitudinal cohort study 
of aging and cognition. The participants are American members of a religious congregation, 
the School Sisters of Notre Dame. Between 1991 and 1993, all members who were 75 years 
or older and living in communities in the midwestern, eastern, and southern United States 
were invited to join the Nun Study (N=1,031), and 678 (66%) volunteered to participate. 
These volunteers did not differ significantly from nonparticipants in their average age at 
baseline, mortality rate, race, and country of birth (Snowdon et al., 1996). 
Individuals needed to have at least one follow-up cognitive assessment after their baseline 




had only one cognitive assessment (92 of these 104 died within two years of their initial 
assessment, reflecting the relatively low loss to follow-up in this sample other than through 
attrition by death). More than 87% (504 out of 574) of the participants were followed up until 
death. The remaining 70 individuals were alive at the end of the assessment period and thus 
their remaining cognitive trajectories until death were not observed.  
In this study, individuals who were missing data on APOE status were excluded. 








Figure 6-1 Derivation of analytic sample for testing the potential antagonistic pleiotropy 
effect of apolipoprotein E  
 
6.2.2 Measures 
To test whether APOE-ε4 has an antagonistic effect on cognition, its effect on cognitive 
performance both earlier and later in life must be investigated. In this study, cognitive 
performance earlier in life was measured by highest level of educational attainment, recorded 
based on four categories: grade school, high school, bachelor’s degree, and master’s degree 
or higher. Cognitive performance later in life was measured by longitudinal data on cognitive 
states summarized as patterns of cognitive state changes.  
These longitudinal data were based on approximately annual cognitive assessments from 
1991 until death or the end of the 12th round of assessments. Surviving participants at each 
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assessment were diagnosed with one of the four mutually exclusive cognitive states: 1) 
normal cognition; 2) mild cognitive impairment (MCI); 3) global impairment (GI); or 4) 
dementia. These assessments over time produce a sequence of longitudinal ordinal outcomes 
for each participant that we call a cognitive trajectory. The criteria for assigning individuals 
to these cognitive states have been described previously (Riley et al., 2002; Snowdon et al., 
1996; Tyas et al., 2007) and are summarized briefly below and also in Appendix A, Table 
A.1 (see also Chapter 4, section 4.2.2).  
Normal cognition. Participants with normal cognition had intact cognition in four cognitive 
tests (Riley et al., 2002) in the neuropsychological battery of the Consortium to Establish a 
Registry for Alzheimer's Disease (CERAD) (≥14 for Boston Naming, ≥12 for Verbal 
Fluency, ≥5 for Delayed Word Recall, and ≥9 for Constructional Praxis) (Morris et al., 1989; 
Welsh et al., 1994), intact global cognition based on the MMSE (≥24) (Folstein et al., 1975), 
and intact function in at least four out of five performance-based ADL (i.e., feeding, 
dressing, walking, standing [transferring], and toileting) (Kuriansky & Gurland, 1976; Potvin 
et al., 1972). 
Mild cognitive impairment. Participants with MCI were diagnosed based on having at least 
one specific area of impaired cognition (e.g., memory or naming) based on four cognitive 
tests from the CERAD neuropsychological battery, but with intact global cognition based on 
the MMSE (≥24), intact function in at least four out of five performance-based ADL, and not 
meeting criteria for dementia (Kuriansky & Gurland, 1976; Potvin et al., 1972). The cut-off 




means, consistent with established definitions (Petersen et al., 1997; Petersen et al., 1999; 
Petersen, 2011; Smith et al., 1996). 
Global impairment. Participants with GI were diagnosed based on having impairment in 
global cognitive function (MMSE < 24), in performance-based ADL, or both. They were also 
impaired in at least one out of four tests from the CERAD neuropsychological battery. 
However, participants with GI did not meet criteria for dementia because if they had 
impairment in two areas of cognition, they were intact for performance-based ADL (≥4) 
(Riley et al., 2002; Riley et al., 2005). 
Dementia. For a diagnosis of dementia, a participant had to have an impairment in memory 
and in at least one other cognitive domain based on the CERAD neuropsychological battery, 
impairment in performance-based ADL, and a decline from previous cognitive level 
(Snowdon et al., 1997). The cut-off point used for impairment in each test was identified 
using scores below the 5th percentile of age norms in the CERAD battery (Morris et al., 1989; 
Welsh et al., 1994). 
    APOE status of the participants was identified using genetic material from buccal cells 
collected from living individuals or from cadaveric brain specimens using methods described 
previously (Mortimer et al., 2009; Saunders et al., 1996). Participants with at least one ε4 
allele were classified as APOE-ε4 carriers. Age at each cognitive assessment was calculated 
by subtracting the birth date from the assessment date. 
6.2.3 Analysis 
The analytic approach has been described previously (see Chapter 5, Section 5.2.3). 
Participants were assigned to one of the seven patterns of cognitive state changes using a 
clinically-driven approach, with details on the grouping procedure described previously 
(Chapter 4, Section 4.2.3). In brief, these patterns were defined based on whether individuals 




experienced a reverse transition to a less impaired state, whether they developed dementia, or 
both. 
For bivariate analysis, the average of each continuous covariate was compared across the 
seven patterns using analysis of variance (ANOVA) and, when the assumptions for 
ANOVA—equality of variances or normal distribution for residuals—were not observed, 
using Kruskal-Wallis rank sum testing. For categorical covariates, the proportion of 
observations was compared across the seven patterns using a chi-square test. When more 
than 20% of cells in the contingency table had expected frequencies of less than 5, 
multinomial logistic bias reduction regression modeling of that categorical variable alone 
was used as Fisher’s exact test did not converge given the extensive possible combinations of 
predictors with the seven outcome levels (Kim, 2017; I. Kosmidis & Firth, 2011; I. 
Kosmidis, 2017). 
Multinomial logistic bias reduction regression modeling (I. Kosmidis & Firth, 2011) was 
applied to identify the association between APOE status and educational attainment earlier in 
life. Regular multinomial logistic regression (without bias reduction) could not estimate the 
odds ratio and its corresponding 95% confidence interval for the association between 
educational attainment and membership in Pattern 1 versus Pattern 7 due to sparsity issues; 
specifically, there was no one with high school or lower educational attainment in Pattern 1. 
Multinomial logistic bias reduction regression modeling extends Firth regression (Firth, 
1993) for reduced-bias estimation in full exponential family models using a computationally 
efficient approach (I. Kosmidis & Firth, 2011). This updated model can estimate odds ratios 
and their corresponding confidence intervals for all levels of exposure even when some 
levels of exposure have zero observations in some levels of the outcome variable.  
Multinomial logistic bias reduction modeling (I. Kosmidis & Firth, 2011) was also applied 
to identify the association between APOE status and membership in patterns of cognitive 
state changes, with membership in the most impaired pattern (stable dementia) used as the 
reference category. Goodness of fit for the multinomial logistic regression models was tested 




All analyses were performed using the statistical software package R (version 3.6.1). For 
the bivariate analyses, ANOVA was performed using the aov function, Kruskal-Wallis rank 
sum testing was performed using the kruskal.test function, and chi-square tests were 
performed using the chisq.test function. The brmultinom function from the brglm2 package 
(I. Kosmidis et al., 2018) was used for fitting multinomial logistic regression models with 
bias reduction analyses; the logitgof function from the generalhoslem package was used for 
checking the goodness of fit of these models (Jay, 2019). 
6.2.4 Ethics 
Ethics approval by institutional review boards was obtained from the University of Kentucky 
for the original Nun Study and from the University of Waterloo for the current study (Office 
of Research Ethics number 20174). 
6.3 Results 
APOE-ε4 carriers were more common among participants who had a university degree 
(Bachelor’s degree or higher) than among those with lower levels of education (22% vs. 
16%). However, this association was not statistically significant in bivariate analyses (Table 
6-1). In this analytic sample, the participants were on average 20.91 (SD = 4.43) years old 
when completing high school, 37.98 (SD = 7.29) years old when completing Bachelor’s 















Table 6-1 Apolipoprotein E status by level of education (N=543) 
APOE-ε4 ≤ High school Bachelor’s degree ≥ Master’s degree Total 




















Total 77 224 242 543 
1p-value for the association between APOE and educational attainment = 0.68 




As shown in Table 6-2, participants showed significant differences in baseline age, APOE-ε4 
status, and educational attainment across the seven patterns of cognitive state changes. The 
pattern with stable dementia (Pattern 7) was characterized by older age at baseline (e.g., 
mean = 86.10, SD = 5.36 in Pattern 7 vs. mean = 78.42, SD = 1.97 in Pattern 1), and a higher 
proportion of APOE-ε4 carriers (e.g., 35.8% in Pattern 7 vs. 9.0% in Pattern 1), and those 
with lower educational attainment (e.g., 35.8% with ≤ high school in Pattern 7 vs. 0.0% in 





Table 6-2 Characteristics of participants within seven patterns of cognitive state changes (N=543) 
 Pattern1 1  Pattern 2 Pattern 3 Pattern 4 Pattern 5 Pattern 6  Pattern 7 
Characteristics N = 22 N = 60 N = 139 N = 74 N =37  N = 130 N = 81 
Age2 (years), mean (SD) 78.42 (1.97) 83.42 (5.11) 80.86 (4.40) 82.46 (4.61) 83.10 (5.26) 83.72 (5.28) 86.10 (5.36)*** 
APOE-ε4 carrier n (%)        
     Yes 2 (9.09) 14 (23.33) 13 (9.35) 16 (21.62) 5 (13.51) 37 (28.46) 29 (35.80) 
     No 20 (90.91) 46 (76.67) 126 (90.65) 58 (78.38) 32 (86.49) 93 (71.54) 52 (64.20)*** 
Education n (%)        
     ≤ High school 0 (0.00) 13 (21.67) 9 (6.47) 4 (5.41) 5 (13.51) 17 (13.08) 29 (35.80) 
     Bachelor’s degree 3 (13.64) 25 (41.67) 53 (38.13) 34 (45.95) 16 (43.24) 57 (43.85) 36 (44.44) 
     ≥ Master’s degree 19 (86.36) 22 (36.67) 77 (55.40) 36 (48.65) 16 (43.24) 56 (43.08) 16 (19.75)*** 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement 
without dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive 
decline with dementia, Pattern 7) stable dementia 
2Age at first assessment 
Abbreviations: APOE-ε4 = apolipoprotein E-ε4; SD = standard deviation 
*p < 0.05; **p < 0.01; ***p < 0.001
 
81 
6.3.1 Apolipoprotein E and educational attainment earlier in life 
The first part of assessing the potential antagonistic pleiotropy effect of APOE-ε4 on 
cognition was to test the association between APOE and educational attainment earlier in life. 
Although APOE-ε4 carriers had 1.5 times higher odds of attaining a university degree than 
high school or grade school education, this increase was not statistically significant (Table 6-
3). Place of birth was considered as a potential factor that could influence the association 
between APOE-ε4 and educational attainment earlier in life when educational experiences 
might have been different. However, more than 98% of the participants completed their 
education in the United States. The results were similar in the subsample of participants who 
completed their education in the United States, and thus results from the full sample are 
presented (Table 6-3). 
 
Table 6-3 The association between apolipoprotein E and educational attainment in 
multinomial logistic regression models 
 Bachelor’s degree vs. ≤ high school  ≥ Master’s degree vs. ≤ high school 
 OR (95% CI) OR (95% CI) 
APOE-ε4 carrier 
(vs. non-carrier) 
1.52 (0.76–3.01) 1.52 (0.77–2.99) 
Abbreviations: APOE-ε4 = apolipoprotein E-ε4; CI = confidence interval; OR = odds ratio 
 
6.3.2 Apolipoprotein E and patterns of cognitive state changes later in life 
The second part of assessing the potential antagonistic pleiotropy effect of APOE-ε4 on 
cognition was to test the association between APOE and patterns of cognitive state changes 
later in life. In the unadjusted multinomial logistic bias reduction regression analysis, grade 
school or high school educational attainment (≤ high school) was used as the reference 
category. In the unadjusted analysis, APOE-ε4 carriers had significantly lower odds of 




level (Patterns 1, 2, or 3) than stable dementia (Pattern 7) (Table 6-4). After adjusting for age 
at first assessment and educational attainment, APOE-ε4 carriers had significantly lower odds 
of experiencing any other patterns of cognitive state changes (Patterns 1 to 6) than stable 
dementia. However, the analysis in Section 6.3.3 showed that the association between APOE 
and patterns of cognitive state changes depended on educational attainment. In addition, in 
the fully adjusted model, the covariates age and education were significantly associated with 
cognitive state patterns. Older age was associated with lower odds of experiencing healthier 
patterns of cognitive state changes (Patterns 1 to 6) versus stable dementia (Pattern 7), 
whereas higher levels of education (Master’s degree or higher) were associated with higher 
odds of experiencing healthier patterns of cognitive state changes (Patterns 1 to 6) versus 
stable dementia (Pattern 7). The association for those with a Bachelor’s degree was similar to 
that of a Master’s degree or higher, reaching significance for three healthier patterns of 







Table 6-4 The association between apolipoprotein E and seven patterns of cognitive state changes in multinomial logistic regression models 
 Pattern1 1 vs 7 Pattern 2 vs 7 Pattern 3 vs 7 Pattern 4 vs 7 Pattern 5 vs 7 Pattern 6 vs 7 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Unadjusted        
APOE-ε4 carrier  
(vs. non-carrier) 
0.22 (0.05–0.89) 0.55 (0.26–1.18) 0.19 (0.09–0.39) 0.50 (0.25–1.03) 0.30 (0.11–0.84) 0.71 (0.39–1.30) 
Model adjusted for age        
APOE-ε4 carrier  
(vs. non-carrier) 
0.16 (0.04–0.68) 0.48 (0.23–1.04) 0.15 (0.07–0.32) 0.42 (0.20–0.88) 0.26 (0.09–0.73) 0.63 (0.34–1.17) 
Age at first assessment 0.63 (0.53–0.76) 0.91 (0.85–0.97) 0.80 (0.75–0.85) 0.87 (0.82–0.93) 0.90 (0.83–0.97) 0.92 (0.88–0.97) 
Model adjusted for education      
APOE-ε4 carrier 
(vs. non-carrier) 
0.14 (0.03–0.60) 0.47 (0.22–1.02) 0.14 (0.06–0.30) 0.37 (0.18–0.79) 0.24 (0.08–0.67) 0.57 (0.30–1.06) 
Education (vs. ≤ high school)      
     Bachelor’s degree 6.96 (0.33–148.62) `1.70 (0.73–3.96) 5.56 (2.30–13.44) 7.07 (2.29–21.83) 2.89 (0.95–8.78) 2.88 (1.37–6.08) 
     ≥ Master’s degree 93.68 (4.97–1764.11) 3.46 (1.36–8.84) 19.41 (7.50–50.25) 17.43 (5.31–57.22) 6.86 (2.11–22.29) 6.47 (2.80–14.94) 
Model adjusted for education and age      
APOE-ε4 carrier 
(vs. non-carrier) 
0.12 (0.03–0.53) 0.42 (0.19–0.93) 0.12 (0.05–0.26) 0.33 (0.15–0.71) 0.21 (0.07–0.60) 0.52 (0.27–0.98) 
Age at first assessment 0.67 (0.56–0.80) 0.92 (0.86–0.98) 0.82 (0.77–0.88) 0.89 (0.84–0.96) 0.91 (0.84–0.99) 0.94 (0.89–0.99) 
Education (vs. ≤ high school)      
     Bachelor’s degree 7.33 (0.33–162.38) 1.67 (0.71–3.93) 5.60 (2.22–14.10) 6.96 (2.23–21.76) 2.84 (0.93–8.68) 2.84 (1.34–6.02) 
     ≥ Master’s degree 48.44 (2.47–949.26) 2.78 (1.06–7.29) 12.34 (4.57–33.33) 13.02 (3.89–43.59) 5.37 (1.62–17.84) 5.46 (2.32–12.86) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement 
without dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive 




6.3.3 Modification of the effect of apolipoprotein E-ε4 on cognition later in life through 
higher educational attainment 
The third aim of this study was to test whether higher educational attainment earlier in life 
modified the detrimental effect of APOE-ε4 on cognition later in life. Due to sparse observations 
in some combinations of the seven levels of cognitive outcome and three levels of educational 
attainment, this analysis of interaction could not be performed using an interaction term even 
using the multinomial logistic bias reduction regression modeling. However, analysis of the 
association between APOE and patterns of cognitive state changes stratified by educational 
attainment showed evidence of effect modification. Among individuals with low levels of 
education (high school or less), APOE-ε4 was a significant predictor, with APOE-ε4 carriers 
showing a lower odds of experiencing healthier patterns of cognitive state changes (Patterns 1, 3, 
4, and 5) versus stable dementia (Pattern 7) (Table 6-5). In contrast, among individuals who 
attained a Master’s degree or higher, APOE-ε4 was only associated with lower odds of 
experiencing trajectories of decline and improvement without dementia (Pattern 3) versus stable 
dementia (Pattern 7) (Table 6-5). Furthermore, among individuals who attained a Master’s 
degree or higher, older age was only significantly associated with lower odds of experiencing 
stable normal cognition (Pattern 1) (Table 6-5).    
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Table 6-5 The association between apolipoprotein E and seven patterns of cognitive state changes in multinomial logistic regression 
models stratified by educational attainment 
 Pattern1 1 vs 7 Pattern 2 vs 7 Pattern 3 vs 7 Pattern 4 vs 7 Pattern 5 vs 7 Pattern 6 vs 7 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Subsample with ≤ high school education      
APOE-ε4 carrier (vs. non-carrier) 0.16 (0.04–0.68) 0.48 (0.23–1.04) 0.15 (0.07–0.32) 0.42 (0.20–0.88) 0.26 (0.09–0.73) 0.63 (0.34–1.17) 
Age at first assessment 0.63 (0.53–0.76) 0.91 (0.85–0.97) 0.80 (0.75–0.85) 0.87 (0.82–0.93) 0.90 (0.83–0.97) 0.92 (0.88–0.97) 
Subsample with a Bachelor’s degree      
APOE-ε4 carrier (vs. non-carrier) 0.12 (0.01–2.63) 0.37 (0.11–1.18) 0.13 (0.04–0.42) 0.38 (0.13–1.11) 0.19 (0.04–0.89) 0.32 (0.12–0.83) 
Age at first assessment 0.63 (0.45–0.89) 0.89 (0.80–0.98) 0.78 (0.71–0.86) 0.84 (0.76–0.92) 0.88 (0.78–0.99) 0.91 (0.84–0.99) 
Subsample with a Master’s degree or higher      
APOE-ε4 carrier (vs. non-carrier) 0.23 (0.04–1.24) 0.79 (0.21–3.01) 0.15 (0.04–0.53) 0.41 (0.11–1.50) 0.42 (0.09–2.02) 1.14 (0.37–3.55) 
Age at first assessment 0.75 (0.60–0.94) 1.04 (0.90–1.21) 0.89 (0.78–1.02) 1.01 (0.88–1.16) 1.04 (0.89–1.21) 1.05 (0.92–1.19) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement 
without dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive 
decline with dementia, Pattern 7) stable dementia 




In this study, the potential antagonistic pleiotropy effect of APOE-ε4 on cognition was tested 
by answering three questions: 1) is APOE-ε4 associated with higher educational attainment 
earlier in life?; 2) is APOE-ε4 associated with membership in the least healthy pattern of 
cognition later in life; 3) Does higher education among APOE-ε4 carriers compensate for the 
detrimental effects of APOE-ε4 on cognition later in life? The study results did not support 
the first part of the antagonistic pleiotropy hypothesis for APOE. In contrast, they did support 
the second part of the hypothesis as APOE-ε4 carriers had lower odds than non-carriers of 
experiencing healthier patterns of cognitive state changes than the least healthy pattern 
(stable dementia). In addition, the third part of the hypothesis was supported because higher 
educational attainment was observed to compensate for the detrimental effect of APOE-ε4 on 
cognition later in life, consistent with the scaffolding theory of aging and cognition. Overall, 
as this study did not support the first part of the antagonistic pleiotropy hypothesis for APOE, 
it did not provide support that APOE has an antagonistic pleiotropy effect on cognition. 
However, attaining a Master’s degree or higher compensated for the detrimental effects of 
both carrying an APOE-ε4 allele and older age on cognitive decline later in life.  
The first two questions in testing the antagonistic pleiotropy effect of APOE on cognition 
can be translated to testing an interaction between APOE and age. In this study, the 
interaction between APOE and age was tested by stratified analysis for the association 
between APOE and cognition in the same sample at two different ages (in earlier and later 
life). The measure of cognition across these two time points differed, from the earlier-life 
measures of educational attainment to the later-life measures of cognitive state patterns. 
However, the two cognitive measures were related: higher educational attainment was 
associated with higher odds of experiencing healthier patterns of cognitive state changes. 
Thus, these different measures of cognition from earlier and later life may be considered 
comparable to a certain degree. The results of this study showed some evidence of interaction 
between APOE and cognition. No significant association was observed between APOE and 
earlier-life cognition; however, APOE-ε4 increased the odds of experiencing the least healthy 




The non-significant association between APOE-ε4 and higher educational attainment 
earlier in life observed in this study is consistent with a number of studies that have not found 
such beneficial effects for APOE-ε4 carriers (Bretsky et al., 2003; Hiekkanen, Kurki, 
Brandstack, Kairisto, & Tenovuo, 2009; F. Liu et al., 2010; O'Donoghue et al., 2018), 
although research supporting a beneficial effect of APOE-ε4 on early-life cognition is also 
frequent (Tuminello & Han, 2011). In addition, controversy exists on the neurobiological 
mechanism for an association between APOE and cognition in early life. A wide range of 
neuroimaging research has found that, during a memory task, APOE-ε4 carriers have higher 
brain activity than non-carriers (Filbey, Slack, Sunderland, & Cohen, 2006; Filbey, Chen, 
Sunderland, & Cohen, 2010; Filippini et al., 2009), which is sometimes considered as a sign 
of a beneficial effect of APOE-ε4 on early-life cognition (Mondadori et al., 2006). However, 
other research (Tuminello & Han, 2011), including a recent study by Hodgetts et al. (2019), 
has suggested that this higher brain activity in younger APOE-ε4 carriers may be a result of 
“lifespan systems vulnerability” that increases activity in areas of brain that were affected by 
early neuropathological signs of Alzheimer’s disease (Buckner et al., 2009; de Haan, Mott, 
van Straaten, Scheltens, & Stam, 2012; Jagust & Mormino, 2011). While Tuminello & Han 
(2011) suggested that a lack of a beneficial effect of APOE-ε4 earlier in life constituted 
strong evidence against the antagonistic pleiotropy hypothesis for APOE, they also 
recommended more lifespan studies to test this hypothesis.  
Although in this study APOE-ε4 carriers had higher odds of attaining a university degree 
than non-carriers, this association did not reach statistical significance. However, the non-
significant association between APOE-ε4 and educational attainment earlier in life observed 
in our study may have been influenced by the high level of education in the Nun Study and 
the resultant limited variability in educational level. For example, more than 85% of 
participants attained a university degree, and this rose to 100% among participants with a 
pattern of stable normal cognition. Hubacek et al. (2001) observed a significantly higher 
proportion of APOE-ε4 carriers in their subsample with higher education than APOE-ε2 




compared to the Nun Study in which higher education was defined as a university degree that 
include graduate degrees.  
In addition, some participants of the Nun Study attained their levels of education later in 
adulthood; therefore, studying the association between APOE and educational attainment 
earlier in life extended to middle age. As a result, their late-life cognitive reserve could also 
be a result of lifetime cognitive stimulation, as has been suggested (Y. Stern, 2012).   
The significant association between APOE-ε4 and experiencing the pattern of stable 
dementia versus healthier patterns of cognitive state changes later in life that was observed in 
this study is also similar to results of biological and epidemiological studies that found an 
increased risk of Alzheimer’s pathology and dementia among APOE-ε4 carriers (Chuang et 
al., 2010; Dickson et al., 2018; Glorioso et al., 2019; Llewellyn et al., 2010; Schmechel et al., 
1993). Previous research in the Nun Study also showed that APOE-ε4 was associated with 
the risk of developing cognitive impairment and dementia (Riley et al., 2000; Tyas et al., 
2007), but indicators of cognitive reserve, such as speaking four or more languages, may 
compensate for the detrimental effects of carrying an APOE-ε4 allele or older age on the 
hazard of developing dementia (Hack et al., 2019).  
Finally, our findings that higher education reduced the detrimental effect of APOE-ε4 on 
late-life cognition have been reported previously (Arenaza-Urquijo et al., 2015; Reas et al., 
2019; Tyas et al., 2007) and support the scaffolding theory of aging and cognition (Park & 
Reuter-Lorenz, 2009; Reuter-Lorenz & Park, 2014). APOE-ε4 carriers might thus have had 
higher odds of recruiting the frontal cortical regions after task-related regions of the brain 
developed impairments due to declines in neural structure and function in other regions of the 
brain in older age (Park & Reuter-Lorenz, 2009; Tuminello & Han, 2011). This transfer of 
the beneficial effect of higher education to late-life cognition could then lead to reverse 
transition to a higher cognitive level and prevention of dementia among APOE-ε4 carriers 





Overall, this study did not support the first part of the antagonistic pleiotropy hypothesis; 
however, it supported the second part of the hypothesis for individuals with lower education. 
Therefore, the results of this study did not support the antagonistic pleiotropy hypothesis. On 
the other hand, this study supported the scaffolding theory of aging and cognition in that 
higher education could compensate for the detrimental effect of APOE-ε4 on late-life 
cognition. 
Strengths of this study included characteristics of the underlying data from the Nun Study 
as well as the analytic approach. The most important strength of the Nun Study for this 
research is the availability of APOE genotyping and cognitive performance data both earlier 
and later in life, with later-life cognition being collected over 15 years. These data provide a 
unique opportunity to test the antagonistic pleiotropy effect of APOE on cognition within the 
same individuals, whereas most previous research has been conducted either on younger or 
older samples. Other strengths of the Nun Study are that it is a community-based (as opposed 
to a clinic-based) sample, which provides a natural cognitive trajectory based on the study 
design’s fixed times for cognitive assessments (vs. need-based cognitive assessments in 
clinical records of cognitive assessments). In addition, the extensive longitudinal data had 
low levels of attrition and missing assessments, providing a robust data set for identifying 
patterns of cognitive state changes. Identification of two levels of cognitive impairment 
between normal cognition and dementia (MCI and GI) provided a more detailed perspective 
on cognitive trajectories than other studies that typically include only MCI.  
The homogeneity of the study participants controlled for many potential confounding 
factors: for example, participants were all similar in marital status, income, social support, 
alcohol and tobacco use, and access to healthcare. Certain lifestyle factors, such as physical 
inactivity, high saturated fat consumption, and alcohol and tobacco use are associated with an 
increased risk of developing dementia especially among individuals carrying at least one 
APOE-ε4 allele (Kivipelto et al., 2008). The effect of APOE-ε4 on cognition is less 




Strengths of our analytic approach include identifying multiple patterns of cognitive state 
changes, thus providing an appropriate perspective for studying cognitive trajectories. A 
strength of the approach used to identify the patterns of cognitive state changes is that it 
distinguishes groups of individuals with different cognitive trajectories, which is 
conceptually a meaningful addition to modeling approaches that assign one average pattern 
to the whole sample. These patterns were determined to be preferable to an alternative set 
identified using latent class mixed-effects modeling (see Chapter 4). In addition, bias 
reduction multinomial logistic regression models were used to model the association between 
covariates and patterns of cognitive state changes. This analytic method is able to estimate 
point estimates (ORs) and their corresponding confidence intervals for all levels of exposure 
and outcome even when no observations were available for some categories. However, using 
bias reduction multinomial logistic regression to estimate associations for categories with 
zero or few observations has limitations: these estimations are less meaningful and 
interpretable due to wide confidence intervals. The goodness of fit for all multinomial models 
was not rejected; however, statistically, the validity of these tests in the presence of sparse 
observations needs to be checked in future research.    
Limitations of the Nun Study included that its participants were 75 years or older at 
baseline. Carrying an APOE-ε4 allele shifts the onset of Alzheimer’s disease, the most 
common type of dementia, to a younger age (Spinney, 2014). Therefore, our results on the 
effects of APOE-ε4 on patterns of cognitive state changes may have been subject to survival 
bias. There were no data on cognitive trajectories before 75 and some participants already 
had dementia at the beginning of the study. In addition, those with normal cognition at the 
first assessment might previously have had mild or global impairment but reverted to normal 
cognition by the beginning of this study. These missed observations may have varied by 
APOE-ε4 status.  
Nun Study participants are a special population of women who are not representative of the 
general population of older women in the United States, and so the results of this research 




level of educational attainment; however, the prevalence of dementia was similar to that of 
the general population (21% in the Nun Study; 20-25% in the general population) (van der 
Flier, Pijnenburg, Fox, & Scheltens, 2011). The homogeneity of the Nun Study participants 
regarding gender and other lifestyle factors also limited the ability to identify the effects of 
these factors on patterns of cognitive trajectories.  
Cognitive assessments were performed at specific times, pre-identified by the study design. 
Therefore, cognitive states might have changed between two observed states. Experiencing 
improvement from cognitive impairment to normal cognition might be due to treatment of 
factors that lead to cognitive impairments, such as thyroid problems. However, data on such 
interventions were not available in this study.  
While APOE-ε4 is primarily a risk factor for Alzheimer’s disease and vascular dementia, 
in this study its effect was studied on patterns of cognitive change including all-cause 
dementia. Therefore, the effect of APOE-ε4 observed in this research questions was 
potentially weakened by other types of dementia. Understanding the effect of APOE-ԑ4 on a 
measure of cognition (educational attainment) earlier in life, and patterns of cognitive state 
changes later in life may lead to efforts for the prevention or delay of dementia. For example, 
these results will provide basic knowledge of cognitive trajectories for researchers working 
on gene therapies and pharmacological approaches to reduce the risk of dementia in APOE-
ε4 carriers. Based on the results of this research, these researchers have a better 
understanding of the potential patterns of cognitive change for older adults based on their 
educational level and APOE-ε4 status.  
The results of this research, while preliminary, suggest that higher educational attainment 
in APOE-ε4 carriers may compensate for the detrimental effect of APOE-ε4 on cognition 
later in life. Therefore, promoting and supporting higher educational attainment may 
contribute to cognitive reserve and healthier cognitive aging later in life. Further research 
will be needed to determine the potential of such effect modification in other populations. In 
addition, identifying the association between APOE and intellectual factors other than 




might modify the effect of APOE on late-life cognition will provide a more comprehensive 







The overall purpose of this study was to identify the longitudinal patterns of cognitive state 
changes and the factors associated with those patterns in older adults. This purpose was 
addressed through the specific aims of three separate but interconnected studies (Chapters 4 
to 6). The first study (Chapter 4) identified and compared patterns of cognitive state changes 
among older adults using two diverse methods. Predictors of these temporal patterns of 
cognitive state changes identified by the preferred method were then investigated in the 
second and third studies. The second study (Chapter 5) determined their association with 
academic achievement (educational attainment and academic performance). The third study 
(Chapter 6) investigated the association of APOE-ε4 with cognition both earlier and later in 
life, where earlier-life cognition was measured using educational attainment and later-life 
cognition was measured using patterns of cognitive state changes. Educational attainment 
was also examined as a potential modifier of the association between APOE status and 
patterns of cognitive state changes later in life.  
In Chapter 4, using longitudinal data from the Nun Study, cognitive aging was modeled 
through trajectories of change across four cognitive states: normal cognition, mild cognitive 
impairment (MCI), global impairment (GI), and dementia. Individuals were grouped into 
distinct patterns of cognitive state changes using two methods: a clinically-driven approach 
and a statistical modeling approach, latent class mixed-effects modeling (lcmm). Using the 
clinically-driven approach, cognitive state changes were clustered into seven distinct patterns 
distinguishing between trajectories with and without cognitive improvement, and with and 
without progression to dementia. In contrast, the lcmm approach identified four latent classes 
of cognitive state changes from better cognitive function (Class 1) to worse (Class 4). The 





cognitive state changes because of the ability of these patterns to capture more clinically 
meaningful details compared to the latent classes identified using the lcmm approach.  
The types of cognitive state changes observed in Chapter 4 are consistent with those 
previously reported. Evidence of reverse transition from cognitive impairment to normal 
cognition has been noted within the Nun Study as well as other populations (Abner et al., 
2012; Iraniparast et al., 2016; Koepsell & Monsell, 2012; Malek-Ahmadi, 2016). Categories 
of cognitive decline observed using our two analytic methods were also reported in previous 
studies of transitions from normal cognition to MCI and from MCI to dementia using multi-
state Markov modeling (Kryscio et al., 2008; Riley et al., 2000; Tyas et al., 2007). In 
addition, the patterns of cognitive state changes that were identified using the clinically-
driven approach expand patterns that were reported previously by Aiken-Morgan et al. 
(2017). While broadly consistent with these findings, Chapter 4 expands previous studies on 
cognitive aging to model the broad definition of cognitive states through temporal patterns of 
cognitive state changes including decline and improvement each with or without progression 
to dementia.  
In Chapter 5, higher academic achievement, as evidenced by educational attainment or 
performance in high school courses, was associated with cognitive reserve through 
experiencing healthier patterns of cognitive state changes than the reference pattern of stable 
dementia. The results suggest that academic achievement can contribute to cognitive reserve 
through four categories of evidence: 1) better cognitive performance upon reaching older 
age; 2) slower rate of cognitive decline; 3) delayed onset of dementia or delayed accelerated 
decline; and 4) reversion from a more to less impaired cognitive state. First, results reflecting 
a higher cognitive level upon reaching older age among more highly educated participants 
are consistent with previous research that found higher educational attainment was associated 
with better cognitive performance upon reaching adulthood or older age (Alley et al., 2007; 
McDermott et al., 2016; Mungas et al., 2018; Y. Stern et al., 2018; Tucker-Drob et al., 2009; 





achievement was associated with patterns of cognitive state changes consistent with a slower 
cognitive decline is congruous with reports of an effect of higher education on slower rates of 
decline (Alley et al., 2007; McDermott et al., 2016; Reas et al., 2017; Zahodne et al., 2015). 
Third, in our study, higher academic achievement increased the odds of experiencing 
trajectories of cognitive decline without dementia. For those individuals who did progress to 
dementia, higher educational attainment increased the odds of experiencing a pattern of fewer 
years with dementia. Both results provide evidence of a delayed onset of dementia. Similar 
effects of delay in progressive cognitive decline have previously been observed through 
delayed accelerated decline (Clouston et al., 2019; Hall et al., 2007; Y. Stern et al., 2018). 
Fourth, higher educational attainment distinguished membership in a pattern of cognitive 
decline and improvement from a pattern of stable dementia. This supports previous research 
that higher educational attainment builds cognitive reserve that may lead to reverse transition 
from MCI to normal cognition (Canevelli et al., 2016; Sachdev et al., 2013; Xue et al., 2019).  
The third study (Chapter 6) used the same longitudinal data as the studies in Chapters 4 
and 5. The results from Chapter 6 did not support the first part of the antagonistic pleiotropy 
hypothesis for APOE: that APOE-ε4 is associated with higher cognitive abilities earlier in 
life (in this study measured by educational attainment). However, results did support the 
second part of the hypothesis, finding that APOE-ε4 was associated with lower cognitive 
performance later in life. APOE-ε4 carriers had lower odds than non-carriers of experiencing 
healthier patterns of cognitive state changes than the least healthy pattern (stable dementia). 
The third part of the hypothesis was also supported because higher educational attainment (a 
graduate degree) was observed to compensate for the detrimental effect of APOE-ε4 on 
cognition later in life. Overall, as this study did not support the first part of the antagonistic 
pleiotropy hypothesis for APOE, it did not provide support that APOE has an antagonistic 
pleiotropy effect on cognition. Matching this part of the results from Chapter 6 to the 





compensate for the detrimental effects of APOE-ε4 and older age on cognition later in life, 
and the level of reserve increased with higher levels of education. 
The lack of a significant association between APOE-ε4 and higher educational attainment 
earlier in life observed in Chapter 6 is consistent with a number of studies that have also not 
found such beneficial effects for APOE-ε4 carriers (Bretsky et al., 2003; Hiekkanen et al., 
2009; F. Liu et al., 2010; O'Donoghue et al., 2018), although research supporting a beneficial 
effect of APOE-ε4 on early-life cognition has also been frequently reported (Tuminello & 
Han, 2011). In addition, controversy exists on the neurobiological mechanism for an 
association between APOE and cognition in early life. A wide range of neuroimaging 
research has found that, during a memory task, APOE-ε4 carriers have higher brain activity 
than non-carriers (Filbey et al., 2006; Filbey et al., 2010; Filippini et al., 2009), which is 
sometimes considered as a sign of a beneficial effect of APOE-ε4 on early-life cognition 
(Mondadori et al., 2006). However, other research (Tuminello & Han, 2011) including a 
recent study by Hodgetts et al. (2019), has suggested that this higher brain activity in younger 
APOE-ε4 carriers may be a result of “lifespan systems vulnerability” that increases activity in 
areas of brain that were affected by early neuropathological signs of Alzheimer’s disease 
(Buckner et al., 2009; de Haan et al., 2012; Jagust & Mormino, 2011).  
The significant association between APOE-ε4 and experiencing the pattern of stable 
dementia versus healthier patterns of cognitive state changes later in life that was observed in 
Chapter 6 is also consistent with the results of biological and epidemiological studies that 
found an increased risk of Alzheimer’s pathology and dementia among APOE-ε4 carriers 
(Chuang et al., 2010; Dickson et al., 2018; Glorioso et al., 2019; Llewellyn et al., 2010; 
Schmechel et al., 1993). Previous research in the Nun Study also showed that APOE-ε4 was 
associated with the risk of cognitive impairment and dementia (Riley et al., 2000; Tyas et al., 
2007). Finally, the reduced detrimental effect of APOE-ε4 on late-life cognition among 





previous reports for other types of cognitive outcomes (Arenaza-Urquijo et al., 2015; Reas et 
al., 2019; Tyas et al., 2007).     
This dissertation has several strengths in its examination of the longitudinal patterns of 
cognitive state changes and their predictors in older adults, including characteristics of the 
underlying data from the Nun Study as well as the analytic approaches. The Nun Study is a 
longitudinal study with annual cognitive assessments over 15 years of follow-up with 
available data on two measures of academic achievement earlier in life and on APOE, the 
most significant genetic risk factor for dementia. This rich data set allowed: 1) identification 
of distinct temporal patterns of cognitive state changes; 2) investigation into how academic 
achievement may contribute to cognitive reserve; and 3) examination of the effect of APOE 
on both early and late-life cognition in the same analytic sample to test the antagonistic 
pleiotropy hypothesis. In addition, the Nun Study provides a robust data set for studying 
cognitive aging because few participants missed follow-up assessments. Assessments 
included specific cognitive domains and overall cognition as well as functional ability 
measured through activities of daily living. The homogeneity of the study participants 
controlled for many potential confounding factors. In addition, this community-based sample 
provided the opportunity to model natural cognitive trajectories. These trajectories are 
relevant particularly when interventions are not possible or feasible due to financial 
constraints or other health conditions, or when interventions do not help to modify 
progression.   
Both analytical approaches that were used in Chapter 4 have specific strengths in 
identifying distinct patterns or classes of cognitive state changes in older adults. A strength of 
the clinically-driven approach is in providing patterns that are more likely to be clinically 
meaningful than the results of the statistical modeling lcmm approach. The clinically-driven 
approach that was used in Chapter 4 can be modified and applied to other studies of aging 
and cognition with ordinal cognitive state levels. A strength of the lcmm approach is in its 





addition, in contrast with the clinically-driven approach, the lcmm approach models the 
actual age at cognitive assessments rather than the order of assessments. Finally, both the 
clinically-driven and the lcmm approaches allow inclusion of participants who miss some 
follow-up assessments (Proust-Lima et al., 2017).  
Comparing the results of the clinically-driven approach with the lcmm approach (Chapter 
4) allowed for assessment of the performance of this statistical modeling approach in terms 
of its ability to identify clinically meaningful latent classes that could be applied more often 
in the future to longitudinal studies of aging and cognition. This comparison provided 
knowledge on the potential clinical aspects of cognitive trajectories that might be missed in 
the lcmm approach and potential factors that cannot easily be considered in a clinically-
driven approach.  
In addition, the bias reduction multinomial logistic regression models that were used in 
Chapters 5 and 6 to model the association between covariates and patterns of cognitive state 
changes allowed estimation of odds ratios and their corresponding confidence intervals for all 
levels of exposures and outcomes when regular multinomial logistic regression was unable to 
estimate these parameters. While application of these bias reduction models can be 
computationally very intensive, recent software developments (brglm2) package (I. Kosmidis 
et al., 2018) has made their application easier and efficient.  
This dissertation also has limitations. While the goal of this work was not to predict 
patterns of cognitive state changes in other population of older adults, generalizability of the 
results is likely of interest. The Nun Study participants are a special population who are not 
representative of the general population of older women in a general population, so over-
interpretation should be avoided. Also, while annual cognitive assessments were frequent 
enough to capture most details of cognitive trajectories, some transitions may have happened 
between assessments. Data collection for the Nun Study began after age 65 when cognitive 
impairment and dementia might have already begun; therefore, cognitive trajectories before 





of the data collection could not be observed for their full cognitive trajectories. Finally, 
treatment of factors that led to cognitive impairment could contribute to reverse transitions 
from MCI to normal cognition. However, data on such potential interventions were not 
available.  
Limitations of the analytical approaches in Chapter 4 vary by the type of approach used to 
identify the distinct patterns of cognitive state changes. Applying the clinically-driven 
method to identify patterns of cognitive state changes was time-intensive. However, now that 
these patterns have been identified, this approach can be more easily applied to other 
populations. The lcmm approach identified meaningful classes of cognitive state changes; 
however, some clinically meaningful details of trajectories were not captured. Lack of a good 
fit of the lcmm model to the data set (i.e., not a good absolute fit) could explain why some 
clinically meaningful details of the cognitive state changes were not captured using the 
statistical modeling approach. The BIC and average posterior probabilities that were used to 
identify the best lcmm model were only able to check the relative fit of the models with 
different numbers of latent classes; a standardized method for checking the absolute fit of an 
lcmm model is not trivial and is not currently available. However, the goodness of fit of the 
lcmm models was checked by a geriatrician for face validity. In addition, using bias 
reduction multinomial logistic regression to estimate associations for categories with zero or 
few observations causes difficulties for interpretation when there are wide confidence 
intervals. In Chapters 5 and 6, the goodness of fit tests for all multinomial models was not 
rejected; however, statistically, the validity of these tests in the presence of sparse 
observations, needs to be checked in future research.    
Further research is needed to determine patterns of cognitive trajectories in other 
populations and their predictors to target interventions of modifiable risk factors and promote 
healthy cognitive aging. Future research is also needed to examine how type and timing of 
interventions may influence cognitive trajectories. More studies are needed to test how 





reserve. Finally, this study on the potential antagonistic pleiotropy effect of APOE on 
cognition should be repeated in larger populations with more diverse levels of education.    
Despite the limitations mentioned, this dissertation contributes to our understanding of 
healthy cognitive aging and its predictors. Overall, the trajectories of cognitive aging seen in 
this dissertation were heterogeneous and included substantial proportions of older adults in 
trajectories reflecting cognitive reserve. A possible explanation for this heterogeneity in 
patterns of cognitive state changes includes intellectual and genetic factors, such as those 
investigated in this dissertation. Higher academic achievement can contribute to building 
cognitive reserve through higher cognitive levels upon reaching older age, a slower rate of 
cognitive decline, reversion to a higher cognitive level after showing signs of impairment, 
and, when dementia does occur, a delay in its onset. Understanding the association between 
academic achievement and cognitive aging can contribute to developing strategies to develop 
cognitive reserve and promote healthy cognitive aging. In addition, understanding the 
association between APOE and earlier and later-life cognition may be useful for researchers 
targeting APOE to develop interventions that consider non-genetic factors that may modify the effect 
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Appendix A  
Diagnosis for cognitive states in the Nun Study 











Activities of Daily Living (ADL) ≥ 4  ≥ 4  Impairment in ADL or 
MMSE  
Impaired in ADL  
Global Cognition    
     MMSE  ≥ 24 ≥ 24  Impaired (< 24)  
CERAD neuropsychological battery     
     Delayed Word Recall  ≥ 5  < 5 Impaired in at 
least one 
< 5 Impaired in at 
least one 
Impaired (< 4)  
     Boston Naming  ≥ 14 < 14 < 14 < 13 
Impaired in at 
least one 
     Verbal Fluency  ≥ 12 < 12 < 12 < 11 
     Constructional Praxis  ≥ 9  < 9 < 9 < 8 
Decline in function from a previous level    Present  
Abbreviations: ADL = Activities of daily living: feeding, dressing, walking, standing [transferring], and toileting; CERAD = Consortium to Establish 





Appendix B  
Tabular overview of similar and dissimilar cognitive trajectories in the 
Nun Study 
Table B-1 Overview of similar cognitive trajectories in the Nun Study: decline and improvement 
without developing dementia  
  Assessment Wave Death 
  1 2 3 4 5 6 7 8 9 10 11 12  
Participant Age 81 82 84 86 87 88 90 91 92 93 94 95 95 
154 Cognitive state1  3 4 4 3 4 4 4 4 4 3 4 4 N.A. 
 Age 78 79 80 82 83 85 87 88 89 90 91 92 93 
258 Cognitive state 4 3 3 3 4 4 3 4 4 2 3 2 N.A. 
 Age 85 86 88 89 91        92 
361 Cognitive state 3 4 4 3 3        N.A. 
 Age 77 79 81 83 84 85 87 88 89 90 91 92 N.A. 
476 Cognitive state 3 3 4 3 3 3 4 3 2 2 2 2 N.A. 
 Age 79 81 82 84 85 87 88 89 90 91 92 93 N.A. 
577 Cognitive state 4 3 3 2 4 4 3 4 4 3 4 3 N.A. 
1Cognitive state 4 = normal cognition, 3 = mild impairment, 2 = global impairment, 1 = dementia 
 Abbreviation: N.A = not applicable  
 
Table B-2 Overview of similar cognitive trajectories in the Nun Study: progressive decline leading to 
dementia 
  Assessment Wave Death 
  1 2 3 4 5 6 7 8 9 10 11 12  
# Age 77 79 80 82 83 84 86 87 88 89 90 91 N.A. 
1481 Cognitive state1 4 4 4 4 4 2 2 2 1 1 1 1 N.A. 
 Age 76 78 80 82         83 
2491 Cognitive state 2 1 1 1         N.A. 
 Age 83 84 85 87         87 
3494 Cognitive state 3 3 1 1         N.A. 
 Age 77 78 80 82 83 84 86      87 
4525 Cognitive state 2 1 1 1 1 1 1      N.A. 
 Age 92 93 94 96 98 99 101      101 
5527 Cognitive state 3 2 2 1 1 1 1      N.A. 
1Cognitive state 4 = normal cognition, 3 = mild impairment, 2 = global impairment, 1 = dementia 








Appendix C  
Latent class mixed-effects modeling 
Latent class analysis was first introduced by Lazarsfeld and Henry in 1968 to cluster individuals into 
homogeneous groups according to their cross-sectional measurement on variables of interest 
(Lazarsfeld & Henry, 1968). In this thesis, distinct patterns of cognitive state changes were identified 
based on semi-parametric modeling using latent class mixed-effects modeling (lcmm) for longitudinal 
outcomes (Proust-Lima et al., 2017), which are annual cognitive assessments. In lcmm, the term 
“latent classes” refers to those different clusters of individuals who share similar trajectories of 
cognitive state changes over time; “mixed modeling” refers to how both fixed and random effects 
explain the trajectories of cognitive state changes.  
The participants of the Nun Study are assumed to have 𝐺 heterogeneous patterns of cognitive state 
changes (latent classes). For each participant, 𝑖, in the sample of 574 individuals (𝑖 = 1, 2, … , 574), a 
vector of 𝑛𝑖 repeated cognitive assessments is available that can be shown as 𝑌𝑖 =
(𝑌𝑖1, 𝑌𝑖2, . . , 𝑌𝑖𝑗 , … , 𝑌𝑖𝑛𝑖)
𝑇, where 𝑌𝑖𝑗 is the cognitive state for each individual 𝑖 at assessment 𝑗 that was 
performed at time 𝑡𝑖𝑗 and 𝑇 represents the transposed matrix that is a new matrix whose rows are the 
columns of the original matrix. The underlying latent process for participant i, Ʌ𝑖(t), is modeled 




𝑇𝑢𝑖𝑔 + 𝜔𝑖(𝑡𝑖𝑗) 
where 𝑐𝑖 is the latent variable with up to 𝐺 groups (𝑐𝑖 = 1, 2, … , g, … , 𝐺). 𝑋𝐿1𝑖(𝑡)  is the vector of 
covariates with common population-level fixed effects, 𝛽 ,over latent classes; 𝑋𝐿2𝑖(𝑡)  represents the 
vector of covariates with class-specific fixed effects, 𝛼𝑔; 𝑍𝑖(𝑡𝑖𝑗) represents individual-specific 
random effects for subject 𝑖 in each latent class, 𝑢𝑖𝑔; and 𝜔𝑖(𝑡𝑖𝑗) accounts for uncertainty not 
described by the fixed effects and subject-specific random effects and is a zero mean Gaussian 








Appendix D  
Figure of trajectories of cognitive state changes for all participants within 
the same pattern identified using the clinically-driven approach (N = 574) 
In the following figures, black trajectories represent participants who died before the end of the data 
collection period; orange trajectories represent participants who remained alive until the end of the 
data collection. Cognitive states are labelled from 1 to 4, with 4 = normal cognition, 3 = mild 












Age at cognitive assessment 
Figure D-1a First of seven clinically-driven patterns of cognitive state changes: stable normal 






















Age at cognitive assessment 
Figure D-1b Second of seven clinically-driven patterns of cognitive state changes: stable mild 






Figure D-1c Third of seven clinically-driven patterns of cognitive state changes: trajectories 

















Figure D-1d Fourth of seven clinically-driven patterns of cognitive state changes: trajectories 

















Figure D-1e Fifth of seven clinically-driven patterns of cognitive state changes: trajectories 

















Figure D-1f Sixth of seven clinically-driven patterns of cognitive state changes: trajectories 

















Figure D-1g Seventh of seven clinically-driven patterns of cognitive state changes: stable 
dementia cognitive state (N = 87) 
 
















Appendix E  
Figure of trajectories of cognitive state changes for all participants within 
the same latent classes identified using the latent class mixed-effects 












Age at cognitive assessment 































































































Figure E-1 Classes of cognitive state changes based on the latent class mixed-effects modeling 
approach with random intercept, age, and age squared (N = 574) 
Black trajectories represent participants who died before the end of the data collection period; orange 
trajectories represent participants who remained alive until the end of the data collection. Cognitive 
states: 4 = normal cognition, 3 = mild cognitive impairment, 2 = global impairment, and 1 = dementia
















Appendix F Characteristics of participants within patterns of cognitive state changes 
Table F-1 Characteristics of participants within patterns of cognitive state changes (N = 411) 
 Patterns1 of cognitive state changes  
Characteristics 1 2 3 4 5 6 7 Total 
Mean age, years (SD)          
     Age at first assessment    78.32 (1.91) 83.16 (4.73) 80.97 (4.32) 81.99 (4.36) 82.91 (5.68) 83.55 (5.16) 86.13 (5.40)*** 82.64 (5.09) 
     Age at last assessment 86.58 (5.08) 87.87 (5.43) 90.37 (4.32) 89.38 (5.31) 93.88 (5.31) 90.86 (4.81) 90.35 (5.44)*** 90.22 (5.15) 
     Age at death 87.35 (4.71) 88.98 (5.27) 90.55 (4.32) 90.00 (5.18) 94.27 (5.72) 91.48 (4.77) 91.23 (5.57)*** 90.82 (5.11) 
Years of follow-up, mean 
(SD) 
8.26 (4.36) 4.71 (3.60) 9.40 (4.05) 7.39 (3.98) 10.96 (3.22) 7.32 (3.63) 4.22 (2.61)*** 7.58 (4.18) 
Years between last 
assessment and death, 
mean (SD) 
2.11 (3.17) 1.33 (1.63) 0.92 (1.03) 1.04 (1.49) 0.56 (0.39) 0.69 (0.51)  0.88 (1.29)** 0.92 (1.25) 
APOE-ε4 allele, n (%)              
     Present 2 (10.53) 7 (20.00) 11 (9.82) 14 (23.73) 5 (16.13) 31 (30.69) 19 (35.19) 89 (21.65) 
     Absent 17 (89.47) 28 (80.00) 101 (90.18) 45 (76.27) 26 (83.87) 70 (69.31) 35 (64.81)** 322 (78.35) 
Education, n (%)         
     ≤ High school 0 (0.00) 1 (2.86) 4 (3.57) 1 (1.69) 2 (6.45) 7 (6.93) 9 (16.67) 24 (5.84) 
     Bachelor’s degree 3 (15.79) 18 (51.43) 45 (40.18) 29 (49.15) 14 (45.16) 50 (49.50) 32 (59.26) 191 (46.47) 
     ≥ Master’s degree 16 (84.21) 16 (45.71) 63 (56.25) 289 (49.15) 15 (48.39) 44 (43.56) 13 (24.07)* 196 (47.69) 
Academic performance         
     GPA, mean (SD) 86.35 (6.75) 88.25 (5.70) 86.97 (6.63) 88.38 (5.46) 86.18 (5.62) 86.14 (6.37) 85.88 (6.35) 86.85 (6.25) 
Total sample 19 35 112 59 31 101 54 411 
Death frequency, n (%) 13 (68.42) 33 (94.29) 87 (77.68) 54 (91.53) 25 (80.65) 98 (97.03) 54 (100) 364 (88.56) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement without 
dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline with dementia, 
Pattern 7) stable dementia 
Abbreviations: APOE-ε4 = apolipoprotein E-ε4; GPA = grade point average; SD = standard deviation 





Table F-2 Characteristics of participants within patterns of cognitive state changes (English subsample, N = 401) 
 
 Patterns1 of cognitive state changes  
Characteristics 1 2 3 4 5 6 7 Total 
Mean age, years (SD)         
     Age at first assessment   78.50 (1.92) 83.16 (4.73) 80.97 (4.34) 82.18 (4.32) 82.79 (5.73) 83.54 (5.19) 86.10 (5.44)*** 82.69 (5.10) 
     Age at last assessment 87.19 (5.00) 87.87 (5.43) 90.34 (4.35) 89.62 (5.21) 93.81 (5.39) 90.90 (4.82) 90.34 (5.49)*** 90.29 (5.12) 
     Age at death 87.64 (4.52) 88.98 (5.27) 90.51 (4.36) 90.26 (5.09) 94.16 (5.81) 91.51 (4.78) 91.21 (5.62)** 90.87 (5.10) 
Years of follow-up, mean 
(SD) 
8.69 (4.36) 4.71 (3.60) 9.37 (4.07) 7.44 (4.01) 11.02 (3.26) 7.36 (3.63) 4.24 (2.63)*** 7.60 (4.19) 
Years between last 
assessment and death, 
mean (SD) 
1.70 (2.81) 1.33 (1.63) 0.95 (1.04) 1.05 (1.52) 0.55 (0.39) 0.68 (0.50) 0.86 (1.30)* 0.91 (1.20) 
APOE-ε4 allele, n (%)          
     Present 2 (11.76) 7 (20.00) 11 (10.09) 13 (22.81) 5 (16.67) 30 (30) 18 (33.96) 86 (21.45) 
     Absent 15 (88.24) 28 (80.00) 98 (89.91) 44 (77.19) 25 (83.33) 70 (7) 35 (66.04)** 315 (78.55) 
Education, n (%)         
     ≤ High school 0 (0.00) 1 (2.86) 4 (3.67) 1 (1.75) 2 (6.67) 7 (7.00) 9 (16.98) 24 (5.99) 
     Bachelor’s degree 3 (17.65) 18 (51.43) 44 (40.37) 28 (49.12) 13 (43.33) 50 (50.00) 31 (58.49) 187 (46.63) 
     ≥ Master’s degree 14 (82.35) 16 (45.71) 61 (55.96) 28 (49.12) 15 (50.00) 43 (43.00) 13 (24.53)* 190 (47.38) 
Academic performance in         
     English, mean (SD) 86.35 (8.42) 86.40 (6.76) 86.52 (7.66) 87.74 (7.10) 85.67 (8.29) 85.13 (7.20) 85.34 (7.91) 86.11 (7.51) 
Total sample 17 35 109 57 30 100 53 401 
Death frequency, n (%) 11 (64.71) 33 (94.29) 84 (77.06) 52 (91.23) 24 (80) 97 (97) 53 (100) 354 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement without 
dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline with dementia, 
Pattern 7) stable dementia 
Abbreviations: APOE-ε4 = apolipoprotein E-ε4; GPA = grade point average; SD = standard deviation 








Table F-3 Characteristics of participants within patterns of cognitive state changes (Latin subsample, N = 368) 
 Patterns1 of cognitive state changes  
Characteristics 1 2 3 4 5 6 7 Total 
Age (years), mean (SD)          
     Age at first assessment    78.33 (1.96) 83.19 (4.79) 81.06 (4.39) 81.68 (3.87) 82.70 (5.90) 83.50 (5.00) 86.36 (5.14)*** 82.59 (5.00) 
     Age at last assessment 86.57 (5.22) 87.77 (5.49) 90.41 (4.47) 89.32 (4.90) 93.69 (5.40) 90.92 (4.69) 90.76 (5.03)*** 90.23 (5.07) 
     Age at death 87.35 (4.71) 88.90 (5.34) 90.57 (4.47) 89.87 (4.73) 94.00 (5.87) 91.54 (4.65) 91.68 (5.16)** 90.81 (5.01) 
Years of follow-up, mean 
(SD) 
8.24 (4.49) 4.59 (3.58) 9.35 (4.13) 7.63 (3.96) 10.99 (3.28) 7.43 (3.68) 4.39 (2.72)*** 
7.64 (4.21) 
Years between last 
assessment and death, 
mean (SD) 
2.11 (3.17) 1.36 (1.65) 0.97 (1.08) 1.01 (1.54) 0.56 (0.40) 0.69 (0.50) 0.92 (1.37)** 
0.95 (1.31) 
APOE-ε4 allele, n (%)              
     Present 2 (11.11) 7 (20.59) 11 (11.00) 14 (25.45) 5 (17.86) 28 (32.56) 15 (31.91) 82 (22.28) 
     Absent 16 (88.89) 27 (79.41) 89 (89.00) 41 (74.55) 23 (82.14) 58 (67.44) 32 (68.09)** 286 (77.72) 
Education, n (%)         
     ≤ High school 0 (0) 1 (2.94) 4 (4.00) 1 (1.82) 2 (7.14) 4 (4.65) 6 (12.77) 18 (4.89) 
     Bachelor’s degree 2 (11.11) 17 (50.00) 39 (39) 26 (47.27) 12 (42.86) 45 (52.33) 29 (61.70) 170 (46.20) 
     ≥ Master’s degree 16 (88.89) 16 (47.06) 57 (57) 28 (50.91) 14 (50.00) 37 (43.02) 12 (25.53)* 180 (48.91) 
Academic performance         
     Latin, mean (SD) 87.44 (6.55) 88.00 (8.37) 87.86 (7.90) 89.09 (7.11) 85.93 (8.65) 86.51 (7.79) 87.5531915 87.54 (7.79) 
Total sample 18 34 100 55 28 86 47 368 
Death frequency, n (%) 13 (72.22) 32 (94.12) 77 (77.00) 50 (90.91) 22 (78.57) 84 (97.67) 47 (100.00) 325 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement without 
dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline with dementia, 
Pattern 7) stable dementia 
Abbreviations: APOE-ε4 = apolipoprotein E-ε4; GPA = grade point average; SD = standard deviation 









Table F-4 Characteristics of participants within patterns of cognitive state changes (algebra subsample, N = 400) 
 Patterns1 of cognitive state changes   
Characteristics 1 2 3 4 5 6 7 Total 
Age (years), mean (SD)          
     Age at first assessment    78.37 (1.95) 83.16 (4.73) 81.04 (4.39) 82.07 (4.36) 82.91 (5.68) 83.61 (5.18) 86.19 (5.43)*** 82.72 (5.12) 
     Age at last assessment 86.95 (4.95) 87.87 (5.43) 90.35 (4.40) 89.47 (5.21) 93.88 (5.31) 90.90 (4.85) 90.45 (5.44)*** 90.28 (5.15) 
     Age at death 87.92 (4.42) 88.98 (5.27) 90.50 (4.42) 90.11 (5.10) 94.27 (5.72) 91.51 (4.81) 91.32 (5.58)*** 90.88 (5.12) 
Years of follow-up, mean 
(SD) 
8.58 (4.25) 4.71 (3.60) 9.31 (4.10) 7.41 (4.00) 10.96 (3.22) 7.29 (3.66) 4.26 (2.62)*** 
7.56 (4.18) 
Years between last 
assessment and death, 
mean (SD) 
2.24 (3.27) 1.33 (1.63) 0.95 (0.06) 1.06 (1.52) 0.56 (0.39) 0.68 (0.51) 0.87 (1.30)*** 
0.93 (1.26) 
APOE-ε4 allele, n (%)              
     Present 2 (11.11) 7 (20) 11 (10.28) 13 (22.81) 5 (16.13) 30 (30.30) 19 (35.85) 87 (21.75) 
     Absent 16 (88.89) 28 (80) 96 (89.72) 44 (77.19) 26 (83.87) 69 (69.70) 34 (64.15)** 313 (78.25) 
Education, n (%)         
     ≤ High school 0 (0) 1 (2.86) 4 (3.74) 1 (1.75) 2 (6.45) 6 (6.06) 9 (16.98) 23 (5.75) 
     Bachelor’s degree 3 (16.67) 18 (51.43) 43 (40.19) 27 (47.37) 14 (45.16) 50 (50.51) 32 (60.38) 187 (46.75) 
     ≥ Master’s degree 15 (83.33) 16 (45.17) 60 (56.07) 29 (50.88) 15 (48.39) 43 (43.43) 12 (22.64)* 190 (47.50) 
Academic performance         
     Algebra, mean 85.72 (8.14) 89.43 (7.47) 87.12 (8.31) 88.91 (7.24) 87.61 (7.34) 86.69 (8.61) 85.58 (8.92) 87.24 (8.20) 
Total sample 18 35 107 57 31 99 53 400 
Death frequency, n (%) 12 (66.67) 33 (94.29) 82 (76.64) 52 (91.23) 25 (80.65) 96 (96.97) 53 (100) 353 (88.25) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement without 
dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline with dementia, 
Pattern 7) stable dementia 
Abbreviations: APOE-ε4 = apolipoprotein E-ε4; GPA = grade point average; SD = standard deviation 









Table F-5 Characteristics of participants within patterns of cognitive state changes (geometry subsample, N = 385) 
 Patterns1 of cognitive state changes   
Characteristics 1 2 3 4 5 6 7 Total 
Age (years), mean (SD)          
     Age at first assessment    78.37 (1.95) 82.84 (4.40) 81.00 (4.35) 82.08 (4.40) 82.43 (5.50) 83.58 (5.24) 86.20 (5.30)*** 82.59 (5.05) 
     Age at last assessment 86.95 (4.95) 87.63 (5.32) 90.39 (4.43) 89.58 (5.24) 93.47 (5.25) 90.87 (4.95) 90.35 (5.61)*** 90.19 (5.16) 
     Age at death 87.92 (4.42) 88.74 (5.17) 90.55 (4.43) 90.21 (5.13) 93.70 (5.67) 91.47 (4.89) 91.06 (5.52)** 90.75 (5.07) 
Years of follow-up, mean 
(SD) 
8.58 (4.25) 4.79 (3.63) 9.40 (4.06) 7.50 (3.98) 11.04 (3.24) 7.29 (3.60) 4.16 (2.51)*** 
7.61 (4.17) 
Years between last 
assessment and death, 
mean (SD) 
2.24 (3.27) 1.35 (1.65) 0.93 (1.06) 1.05 (1.52) 0.55 (0.41) 0.67 (0.48) 0.71 (0.52)*** 
0.91 (1.20) 
APOE-ε4 allele, n (%)              
     Present 2 (11.11) 7 (20.59) 10 (9.43) 14 (24.56) 5 (18.52) 28 (29.79) 17 (34.69) 83 (21.56) 
     Absent 16 (88.89) 27 (79.41) 96 (90.57) 43 (75.44) 22 (81.48) 66 (70.21) 32 (65.31)** 302 (78.44) 
Education, n (%)         
     ≤ High school 0 (0.00) 1 (2.94) 4 (3.77) 1 (1.75) 2 (7.41) 6 (6.38) 8 (16.33) 22 (5.71) 
     Bachelor’s degree 3 (16.67) 17 (50.00) 40 (37.74) 27 (47.37) 10 (37.04) 47 (50.00) 29 (59.18) 173 (44.94) 
     ≥ Master’s degree 15 (83.33) 16 (47.06) 62 (58.49) 29 (50.88) 15 (55.65) 41 (43.62) 12 (24.49)* 190 (49.35) 
Academic performance         
     Geometry, mean 86.78 (8.22) 88.91 (8.17) 86.98 (8.12) 88.32 (7.60) 86.85 (7.93) 86.89 (7.96) 86.06 (7.97) 87.19 (7.96) 
Total sample 18 34 106 57 27 94 49 385 
Death frequency, n (%) 12 (66.67) 32 (94.12) 82 (77.36) 52 (91.23) 21 (77.78) 92 (97.87) 49 (100) 340 (88.31) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement without 
dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline with dementia, 
Pattern 7) stable dementia 
Abbreviations: APOE-ε4 = apolipoprotein E-ε4; GPA = grade point average; SD = standard deviation 





Appendix G  
The association of educational attainment with patterns of cognitive state changes 
Table G-1 The association of educational attainment with membership in patterns of cognitive state changes (English subsample, N = 401) 
 Pattern1 1 vs 7 Pattern 2 vs 7 Pattern 3 vs 7 Pattern 4 vs 7 Pattern 5 vs 7 Pattern 6 vs 7 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Unadjusted       
Education  
(vs. ≤ high school) 
      
     Bachelor’s degree 2.11 (0.08–54.00) 3.27 (0.54–25.68) 2.98 (0.82–10.79) 5.73 (0.85–38.81) 1.63 (0.32–8.26) 2.03 (0.66–6.22) 
     ≥ Master’s degree 20.41 (0.89–469.02) 7.74 (1.07–56.13) 9.62 (2.52–36.72) 13.37 (1.89–94.52) 4.36 (0.83–23.02) 4.08(1.23–13.49) 
Adjusted for age and 
APOE  
      
Education  
(vs. ≤ high school) 
      
     Bachelor’s degree 2.97 (0.10–89.33) 3.74 (0.54–26.00) 3.19 (0.78–13.06) 5.65 (0.80–39.65) 1.66 (0.32–8.60) 1.96 (0.62–6.16) 
     ≥ Master’s degree 16.91 (0.62–461.03) 6.74 (0.90–50.35) 7.55 (1.73–32.89) 10.43 (1.41–77.47) 3.76 (0.68–20.87) 3.43 (0.99–11.92) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement without 
dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline with dementia, 
Pattern 7) stable dementia 










Table G-2 The association of educational attainment with membership in patterns of cognitive state changes (Latin subsample, N = 368) 
 Pattern1 1 vs 7 Pattern 2 vs 7 Pattern 3 vs 7 Pattern 4 vs 7 Pattern 5 vs 7 Pattern 6 vs 7 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Unadjusted       
Education  
(vs. ≤ high school) 
      
     Bachelor’s degree 1.10 (0.04–33.13) 2.57 (0.34–19.58) 1.93 (0.48–7.84) 3.89 (0.52–29.09) 1.10 (0.20–6.21) 2.23 (0.55–8.99) 
     ≥ Master’s degree 17.16 (0.68–433.86) 5.72 (0.72–45.67) 6.64 (1.56–28.37) 9.88 (1.27–76.99) 3.02 (0.51–17.67) 4.33 (1.00–18.73) 
Adjusted for age and APOE       
Education  
(vs. ≤ high school) 
      
     Bachelor’s degree 1.59 (0.04–62.09) 2.47 (0.32–19.07) 2.01 (0.43–9.49) 3.61 (0.45–28.96) 1.07 (0.18–6.25) 2.00 (0.48–8.33) 
     ≥ Master’s degree 13.66 (0.41–457.19) 4.34 (0.54–36.94) 4.70 (0.94–23.57) 6.49 (0.77–54.89) 2.27 (0.36–14.24) 3.19 (0.70–14.58) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement without 
dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline with dementia, 
Pattern 7) stable dementia 












Table G-3 The association of educational attainment with membership in patterns of cognitive state changes (algebra subsample, N = 400) 
 Pattern1 1 vs 7 Pattern 2 vs 7 Pattern 3 vs 7 Pattern 4 vs 7 Pattern 5 vs 7 Pattern 6 vs 7 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Unadjusted       
Education  
(vs. ≤ high school) 
      
     Bachelor’s degree 2.05 (0.08–52.73) 3.61 (0.52–24.99) 2.83 (0.78–10.25) 5.36 (0.79–36.49) 1.70 (0.34–8.57) 2.27 (0.71 –7.24) 
     ≥ Master’s degree 23.56 (1.02–546.42) 8.36 (1.14–61.26) 10.22 (2.64–39.48) 14.95 (2.09–106.67) 4.71 (0.88–25.13) 5.09 (1.46–17.66) 
Adjusted for age and 
APOE  
      
Education  
(vs. ≤ high school) 
      
     Bachelor’s degree 3.13 (0.10–97.09) 3.65 (0.52–25.52) 3.07 (0.74–12.66) 5.35 (0.75–38.01) 1.74 (0.34–9.03) 2.21 (0.68–7.24) 
     ≥ Master’s degree 20.49 (0.73–577.16) 7.34 (0.97–55.61) 8.14 (1.83 –36.13) 11.71 (1.55–88.41) 4.15 (0.74–23.39) 4.35 (1.19–15.90) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement without 
dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline with dementia, 
Pattern 7) stable dementia 





Table G-4 The association of educational attainment with membership in patterns of cognitive state changes (geometry subsample, N = 385) 
 Pattern1 1 vs 7 Pattern 2 vs 7 Pattern 3 vs 7 Pattern 4 vs 7 Pattern 5 vs 7 Pattern 6 vs 7 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Unadjusted       
Education  
(vs. ≤ high school) 
      
     Bachelor’s degree 2.02 (0.08–52.98) 3.36 (0.47–23.91) 2.59 (0.69–9.71) 5.28 (0.76–36.80) 1.21 (0.23–6.47) 2.11 (0.64–6.95) 
     ≥ Master’s degree 21.08 (0.89–497.59) 7.48 (1.00–55.86) 9.44 (2.39–37.33) 13.37 (1.84–97.29) 4.22 (0.77–22.95) 4.34 (1.22–15.48) 
Adjusted for age and 
APOE  
      
Education  
(vs. ≤ high school) 
      
     Bachelor’s degree 2.30 (0.07–74.00) 3.02 (0.42–21.85) 2.32 (0.54–9.93) 4.58 (0.63–33.21) 1.08 (0.20–5.99) 1.91 (0.56–6.48) 
     ≥ Master’s degree 14.49 (0.49–424.19) 5.88 (0.75–45.82) 6.49 (1.41–29.82) 9.46 (1.23–72.95) 3.23 (0.55–18.81) 3.53 (0.93–13.34) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement without 
dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline with dementia, 
Pattern 7) stable dementia 





Appendix H  
The association of academic performance with patterns of cognitive state changes 
Table H-1 The association of academic performance in English or Latin with membership in patterns of cognitive state changes (English 
subsample, N = 401; Latin subsample, N = 368)  
 Pattern1 1 vs 7 Pattern 2 vs 7 Pattern 3 vs 7 Pattern 4 vs 7 Pattern 5 vs 7 Pattern 6 vs 7 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Unadjusted        
English 1.17 (0.57–2.41) 1.20 (0.68–2.11) 1.23 (0.80–1.91) 1.55 (0.93–2.59) 1.05 (0.59–1.89) 0.97 (0.63–1.50) 
Adjusted for age and APOE        
English 1.24 (0.58–2.64) 1.26 (0.71–2.25) 1.31 (0.82–2.10) 1.65 (0.97–2.80) 1.11 (0.61–2.02) 1.02 (0.65–1.59) 
Unadjusted       
Latin 0.97 (0.49–1.93) 1.07 (0.60–1.91) 1.06 (0.67–1.66) 1.31 (0.78–2.22) 0.78 (0.44–1.39) 0.85 (0.54–1.34) 
Adjusted for age and APOE        
Latin 1.11 (0.54–2.28) 1.09 (0.61–1.97) 1.12 (0.69–1.82) 1.39 (0.80–2.41) 0.80 (0.44–1.45) 0.87 (0.55–1.39) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement without 
dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline with dementia, 
Pattern 7) stable dementia 









Table H-2 The association of academic performance in algebra or geometry with membership in patterns of cognitive state changes (algebra 
subsample, N = 400; geometry subsample, N = 385)  
 Pattern1 1 vs 7 Pattern 2 vs 7 Pattern 3 vs 7 Pattern 4 vs 7 Pattern 5 vs 7 Pattern 6 vs 7 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Unadjusted        
Algebra 1.01 (0.54–1.87) 1.79 (1.03–3.10) 1.24 (0.84–1.84) 1.64 (1.03–2.62) 1.32 (0.77–2.27) 1.17 (0.79–1.73) 
Adjusted for age and APOE        
Algebra 1.11 (0.57–2.15) 1.96 (1.13–3.43) 1.41 (0.92–2.15) 1.83 (1.12–2.97) 1.48 (0.86–2.55) 1.25 (0.83–1.87) 
Unadjusted        
Geometry 1.10 (0.57–2.11) 1.57 (0.89–2.79) 1.15 (0.76–1.74) 1.42 (0.88–2.31) 1.12 (0.63–1.98) 1.13 (0.74–1.73) 
Adjusted for age and APOE        
Geometry 1.37 (0.67–2.81) 1.74 (0.98–3.11) 1.33 (0.85–2.08) 1.63 (0.99–2.65) 1.25 (0.70–2.25) 1.23 (0.80–1.89) 
1Pattern 1) stable normal cognition, Pattern 2) stable mild cognitive impairment or stable global impairment, Pattern 3) decline and improvement without 
dementia, Pattern 4) progressive decline without dementia, Pattern 5) decline and improvement with dementia, Pattern 6) progressive decline with dementia, 
Pattern 7) stable dementia 
Abbreviations: APOE-ε4 = apolipoprotein E-ε4; CI = confidence interval; OR = odds ratio 
 
 
  
 
